ࡱ>  q` RPbjbjqPqPP::&%%%%%%%%8T$ %h,Lx"9Md4egggggg$xh5%("9((%%}T = = =(%%e =(e = =ed%%h  BGH/\]f8kMThfTl;2x lphl%h`E  =!\S#<Xh((((%% /$sb%%/%%%%%%%%% Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.q\qge兡N gPlQSShandong Xinhua Pharmaceutical Company Limiteda joint stock company established in the People s Republic of China with limited liability Stock Code: 0719 2011 INTERIM RESULTS ANNOUNCEMENTThe board of directors (the  Board ) and directors (Directors) of Shandong Xinhua Pharmaceutical Company Limited (the Company or Xinhua Pharm) hereby announce the unaudited consolidated results of the Company and its subsidiaries (the Group) for the half year ended 30 June 2011 (the Reporting Period). The following financial information has been prepared in accordance with Hong Kong Generally Accepted Accounting Principles (HKGAAP) and PRC accounting standards. This results announcement (the Announcement) is summarised from the Companys 2011 interim report (the Interim Report) and investors are advised to read the full text of the interim report for full information. The Announcement is published in Chinese and English. The Chinese version shall prevail if there are discrepancies between the Chinese version and the English version. I. COMPANY INFORMATIONChinese Name of the Company : q\qge兡N gPlQSEnglish Name of the Company: SHANDONG XINHUA PHARMACEUTICALCOMPANY LIMITEDLegal Representative: Mr. Zhang DaimingCompany Secretaries: Mr. Cao Changqiu, Ms. Guo LeiTelephone Number: 86-533-2196024Facsimile Number: 86-533-2287508E-mail Address of Company Secretaries: cqcao@xhzy.com, H HYPERLINK "mailto:guolei@xhzy.com" guolei@xhzy.comRegistered Address and Office Address: Chemical Industry Area of Zibo Hi-tech Industry Development Zone, Zibo City, Shandong Province, the Peoples Republic of China (the PRC)Postal Code: 255005Website of the Company: H HYPERLINK "" E-mail Address of the Company: H HYPERLINK "mailto:xhzy@xhzy.com" Uxhzy@xhzy.comUPRC newspaper for information disclosure: Securities TimesWebsite designated by the China Securities Regulatory Commission (the CSRC): H HYPERLINK "http://www.cninfo.com.cn" http://www.cninfo.com.cnListing InformationH SharesStock Exchange: The Stock Exchange of Hong Kong Limited (the SEHK)Abbreviated Name: Shandong XinhuaStock Code: 0719A SharesStock Exchange: Shenzhen Stock Exchange (the SZSE)Abbreviated Name: Xinhua PharmStock Code: 000756a!. SUMMARY OF FINANCIAL RESULTS(i) In accordance with PRC accounting standards (RMB)ItemAs at 30 June 2011(Unaudited)As at 31 December 2010 (the  End of Last Year )(Audited)Change as compared to the End of Last Year (%)Total assets2,852,288,422.282,739,564,533.494.11Total equity attributable to equity holders of Company1,713,018,725.621,676,523,546.192.18Capital457,312,830.00457,312,830.00-Net assets per share attributable to equity holders of Company3.753.672.18Six months ended 30 June 2011(Unaudited)Six months ended 30 June 2010 (the Same Period Last Year)(Unaudited)Change as compared to the Same Period Last Year (%)Total operating income1,522,811,524.541,368,618,869.5411.27Operating profit79,496,686.5871,140,908.6911.75Profit before taxation77,517,940.7674,980,507.523.38Profit attributable to the equity holders of Company60,702,135.8357,881,893.634.87Profit attributable to the equity holders of Company after extraordinary items (Note)60,845,003.7654,449,164.5811.75Basic earnings per share 0.130.13-Diluted earnings per share 0.130.13-Return on equity of weighted average (%)3.563.48Increase 0.08 pointsReturn on equity of weighted average after extraordinary loss (%)3.563.27Increase 0.29 pointsNet cash flow from operating activities27,512,297.58136,981,964.64(79.92)Net cash flow from operating activities per share 0.060.30(80.00)Note:Extraordinary items include:ItemAmount (RMB)NotesProfit or loss from disposal of non-current assets(56,741.13)Loss of disposal of fixed assetsGovernment subsidies recognised in current profit and loss, (excluding those closely related to the Companys normal operations and granted on an ongoing basis under the national policies according to certain fixed quota of amount or volume)165,500.00Received government subsidies reckoned into current termGains (losses) from fair value changes of trading financial assets and trading financial liabilities, and investment income from disposal of trading financial assets, trading financial liabilities and available-for-sale financial assets, except effective hedging activities related to the Companys normal operations1,750,000.00Dividends from available-for-sale financial assetsOther non-operating income or cost except the above items(2,087,504.69)Non-controlling interests534.19Income tax expense85,343.70Total(142,867.93)(ii) In accordance with HKGAAP (RMB000)Consolidated Income StatementItemSix months ended 30 June 2011Unaudited Six months ended 30 June 2010Unaudited Revenue1,509,0291,352,583Profit before taxation76,76477,126Income tax expense(15,305)(13,904)Profit for the period61,45963,222Includes: Profit attributable to owners of the Company60,06160,174Non-controlling interests1,3983,048Consolidated Statement of Financial PositionItemAs at 30 June 2011Unaudited As at 31 December 2010Audited Total assets2,855,598 2,772,599 Total liabilities(1,093,875)(1,048,367)Non-controlling interests(39,648)(38,010)Equity attributable to owners of the Company1,722,075 1,686,222 (iii) Reconciliation of accounts prepared in accordance with PRC accounting standards and HKGAAP (RMB) (Unaudited)ItemProfit attributable to the equity holders of CompanyTotal equity attributable to equity holders of Companythe Reporting PeriodSame Period Last YearAs at 30 June 2011As at 1 January 2011Prepared under HKGAAP60,061,000.0060,174,000.001,722,075,000.001,686,222,000.00Prepared under PRC accounting standards60,702,135.8357,881,893.631,713,018,725.621,676,523,546.19HKGAAP adjustments:Deferred taxation111,864.17145,106.37(1,600,725.62)(1,711,546.19)Provision for education fund(753,000.00)(973,000.00)10,657,000.0011,410,000.00Financial award for Energy-saving technological transformation -3,120,000.00--Total of the difference between the PRC accounting standards and HKGAAP(641,135.83)2,292,106.379,056,274.389,698,453.81Explanation of the difference between the PRC accounting standards and HKGAAP:1. Education fees are set out as per the actual circumstances, without the need of provision under HKGAAP. As at 30 June 2011 provision made for the balance of education fees under the PRC accounting standards was RMB10,657,000 with an amount in education fees of RMB753,000 for this period.2. Education fees also led to the difference in the Companys deferred income tax, with the difference in accumulated deferred income tax of RMB1,600,725.62 and that in deferred income tax of the current period of RMB111,864.17. III. CHANGES IN SHARE CAPITAL STRUCTURE AND INFORMATION ON SHAREHOLDERS1. Share Capital structure30 Jun 20111 Jan 2011Class of sharesNumber of shares (share)% of the total share capitalNumber of shares (share)% of the total share capital1. Total number of conditional tradable shares4,2380.00120,1120.004Stated-owned shares0000Domestic legal person shares0000Conditional tradable senior management A shares4,2380.00120,1120.004Others00002. Total number of unconditional tradable shares457,308,59299.999457,292,71899.996Renminbi ordinary shares (A shares)307,308,59267.199307,292,71867.196Overseas listed foreign shares (H shares)150,000,00032.80150,000,00032.803. Total number of shares457,312,830100.00457,312,830100.00Note: As at 30 June 2011, a total of 11,250,000 shares held by Qingdao Haowei Investment Development Company Limited in the Company have been charged and frozen.2. As at 30 June 2011, the Company had on record a total of 41,032 shareholders, including 58 holders of H Shares and 40,974 holders of A Shares.3. As at 30 June 2011, the ten largest shareholders of the Company were as follows: Unit: shareNumber of ShareholderTypes of shareholdersNumber of shares held% of the total share capitalNumber of conditional tradable shares heldNumber of shares being charged or frozenShandong Xinhua Pharmaceutical Group Company Limited (SXPGC)State-owned shareholder, A shares166,071,83836.3100HKSCC (Nominees) LimitedListed H shares148,095,99832.3800Qingdao Haowei Investment Development Company LimitedDomestic general legal person shares11,536,1432.52011,250,000Zhou QiupingDomestic person1,452,6240.3200Wang CuipingDomestic person731,4000.1600Zhang QilinDomestic person609,6000.1300Zheng HuidanDomestic person499,9900.1100WANG ZHIHAIListed H shares456,0000.1000Huang WanjunDomestic person440,0000.1000Shen GeDomestic person435,0330.10004. As at 30 June 2011, the ten largest shareholders of the unconditional tradable shares of the Company were as follows:Name of ShareholderNumber of unconditional listed shares (share)Class of sharesSXPGC166,071,838A SharesHKSCC (Nominees) Limited148,095,998H SharesQingdao Haowei Investment Development Company Limited11,536,143A SharesZhou Qiuping1,452,624A SharesWang Cuiping731,400A SharesZhang Qilin609,600A SharesZheng Huidan499,990A SharesWANG ZHIHAI456,000H SharesHuang Wanjun440,000A SharesShen Ge435,033A SharesNote:1. The Directors are not aware as to whether there is any association amongst the ten largest shareholders of the Company, nor the persons acting in concert as defined in the Rules for the information Disclosure of Changes in the Shareholding of Listed Companies issued by the China Securities Regulatory Commission (the CSRC). In addition, the Directors do not know whether there is any association amongst the shareholders of H Shares of the Company or persons acting in concert as referred to above. The Directors do not know whether there is any association amongst the ten largest shareholders of unconditional tradable shares of the Company, any association between the ten largest shareholders of the Company or the persons acting in concert as defined in the Rules for the information Disclosure of Changes in the Shareholding of Listed Companies issued by the CSRC.2. The only domestic shareholder with more than 5% of the total issued shares of the Company is SXPGC.3. There was no change of controlling shareholder of the Company during the Reporting Period.4. Save as disclosed above and so far as the Directors are aware, as at 30 June 2011, no other person (other than the Directors, supervisors of the Company (the Supervisors), chief executives or members of senior management of the Company (the Senior Officers)) had an interest or short position in the Companys shares or underlying shares (as the case may be) which would fall to be disclosed to the Company and the SEHK under the provisions of Divisions 2 and 3 of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong (SFO) and as recorded in the register required to be kept under section 336 of the SFO), or was otherwise a substantial shareholder (as defined in the Rules Governing the Listing of Securities on the SEHK (the Listing Rules)) of the Company.IV. DIRECTORS, SUPERVISORS AND SENIOR OFFICERSThe number of shares held by the Directors, Supervisors and Senior Officers of the Company were as follows:NamePositionNumber of Shares (share) as at 1 January 2011Change in number of SharesNumber of Shares (share) as at 30 June 2011Directors:Mr. Zhang DaimingChairmanNilNilNilMr. Ren FulongExecutive DirectorNilNilNilMr. Du DepingExecutive Director, General ManagerNilNilNilMr. Zhao SongguoExecutive Director, Deputy generalmanager & Financial ControllerNilNilNilMr. Xu LieNon-executive Director NilNilNilMr. Zhao BinNon-executive Director NilNilNilMr. Zhu BaoquanIndependent non-executive DirectorNilNilNilMr. Sun MinggaoIndependent non-executive DirectorNilNilNilMr. Kwong Chi Kit, VictorIndependent non-executive DirectorNilNilNilSupervisors:Mr. Li TianzhongChairman of Supervisory CommitteeNilNilNilMr. Liu QiangSupervisor4,370Nil4,370Mr. Zhang YueshunIndependent SupervisorNilNilNilMr. Tao ZhichaoIndependent SupervisorNilNilNilSenior Officers:Mr. Dou XuejieDeputy General ManagerNilNilNilMr. Du DeqingDeputy General Manager NilNilNilMr. He TongqingDeputy General Manager NilNilNilMr. Cao ChangqiuCompany Secretary1,281Nil1,281Ms. Guo LeiCompany SecretaryNilNilNilTotal5,651Nil5,651All shares held by the Directors, Supervisors and Senior Officers are A shares. The number of shares held by the Directors, Supervisors and Senior Officers has no change during this Reporting period.So far as the Directors, Senior Officers and Supervisors are aware, save as disclosed above, as at 30 June 2011, no Director, Senior Officer or Supervisor had any interest or short position in the shares, underlying shares and / or debentures (as the case may be) of the Company or any of its associated corporations (as defined in Part XV of the SFO) which was required to be notified to the Company and the SEHK pursuant to Divisions 7 and 8 of Part XV of the SFO (including any interest or short position which any such Director, Senior Officer or Supervisor is taken or deemed to have under such provisions of the SFO) or which was required to be entered in the register required to be kept by the Company pursuant to Section 352 of the SFO or which was otherwise required to be notified to the Company and the SEHK pursuant to the Model Code for Securities Transactions by Directors of Listed Issuers as contained in Appendix 10 to the Listing Rules.CHANGES OF DIRECTORS, SUPERVISORS AND SENIOR OFFICERSDuring this Reporting Period, there were no changes of Directors, Supervisors and Senior Offices.V. CHAIRMANS STATEMENTDear shareholders,I am pleased to report the operating results of the Company for the six months ended 30 June 2011.For the six months ended 30 June 2011, pursuant to the PRC accounting standards, the operating income of the Group was RMB1,522,812,000 and net profit attributable to equity holders of the Company was RMB60,702,000, representing an increase of 11.27% and an increase of 4.87% respectively, as compared to that of the same period last year.The Group had a turnover of RMB1,509,029,000 and the profit attributable to owners of the Company of RMB60,061,000 for the six months ended 30 June 2011under HKGAAP, representing an increase of 11.57% and a decrease of 0.19% respectively, as compared with that of the same period last year.The Board did not recommend the payment of an interim dividend for the six months ended 30 June 2011.BUSINESS REVIEWIn the first half of 2011, the Group accomplished the business objectives set at the beginning of the year by taking proactive measures against a series of adverse factors such as the surging price of raw materials and energy, increased pressure on the tender system for domestic pharmaceutical products and on environmental protection, the further tightening monetary policies by the State, and appreciating Renminbi. The Group made the following achievements for the period: 1. Increased efforts to explore markets and strived to increase sales During the first half of 2011, the Company continued to deepen strategic partnerships with its customers and paid great attention to the development of international markets. Leveraging on its advantages in brand, quality and unique products, the Company consolidated its key markets and key customers and vigorously explored emerging markets. It increased efforts in the building of the third terminal network with focus on clinical marketing teams for high-end hospitals while concentrating on the cultivation of key products and strategic products. As such, for the first half of 2011, the Company recorded a double-digit growth in the sales of preparation products despite many difficulties, a year-on-year increase of 21.37% in its revenue from exports and a year-on-year increase of 100% in the external sales of pharmaceutical intermediates at its Shouguang Park.2. Aggressively promoted R&D of new products, accelerated the launch of new products, proactively advanced technological progress and managed to reduce costsThe Company accelerated its strategic deployment of new products and construction of R&D platforms, completing the deployment of 49 strategic products and the initiation of 14 new projects in the first half of the year. The Company deepened collaboration among production, academy and research and reached an intent of cooperation with a number of domestic and overseas research universities and institutions.The Company proactively worked on those technical breakthrough projects set out at the beginning of the year, with progress made in the process improvements of products including Ibuprofen, and the successful commencement of production for two new products, namely amlodipine besylate and sumatriptan succinate. In the first half of 2011, the Company saved a total of approximately RMB9,740,000 worth of raw materials and power consumption, and was granted two invention patents and one new utility model patent. 3. Steadily advanced construction of parks and projects During the first half of 2011, the Company commenced construction of the phase-1 relocation project for the Hutian Park and completed the civil work on the plants for the aspirin and salicylic acid relocation and renovation projects as well as the initial explosion work for the sewage treatment project. It also commenced construction for the multi-functional workshop project and completed the process design for the Analgin series products.The capacity expansion and renovation projects of pharmaceutical intermediates at Shouguang Park and the serial development of product projects, either completed or currently under preliminary verification and project design, will be carried out in a stable, progressive and economical manner as planed, and built into the Company's "industrial base for precision chemical engineering ". The first half of 2011 also saw Shouguang Park maintain its rapid growth momentum. 4. Improved corporate management and boosted comprehensive competitiveness The Company considerably enhanced its on-site management levels. In the first half of 2011, the Company successfully passed the audit of its tablets workshop by the British Department of Health, the GMP audit of isopropyl karthikeyan antipyrine by Germany, the on-site inspection into pazufloxacin mesylate and the injection of pazufloxacin mesylate by the State Food and Drug Administration, as well as quality audits by 16 customers including GSK. In particular, the passing of the MHRA audit resulted in the award of a passport for the Company's preparation products to access the European markets. While adhering to the online tendering and procurement model, the Company cut back on exclusive suppliers and agents, made thorough market forecasts and analyses, and fully utilized both the domestic and overseas markets to lower procurement costs. 5. Steady operation in safety and environment protection and remarkable results in energy conservation and emission reductionThrough implementing standardized work safety on the basis of teams/groups and strengthening efforts in improving production techniques and the application of new environment-friendly technologies, the Company maintained a steady operation in terms of safety and environmental protection and did not have any major safety incidents or environment-related accidents in the first half of the year.By actively promoting the application of the "Four New" technologies, coupled with the application of its online energy management system, the Company worked intently on energy conservation and emission reduction and recorded a remarkable further 4.47% drop in energy consumption per RMB10,000 production value during the first half of 2011.PLANS FOR THE SECOND HALF OF THE YEAR 2011In the face of a complex and volatile environment, the Group will take and strictly implement practical countermeasures in the second half of 2011. All in all, the Group will focus on the following: 1. Press ahead with product R&D and sales, and boost the core competitiveness of the Company. The Group will try all means to boost the innovation awareness of all staff, step up scientific research efforts, accelerate industrialization of scientific research results, aggressively drive technological progress, innovation and application, lower manufacturing costs, and boost product quality and yield. By adapting to the ever-changing external environment, the Group will formulate effective measures, strengthen efforts in product market development, fully leverage its advantage of the international certification of its products, and accelerate exploration of international markets while emphasizing control of operating risks and enhancing economic operation quality. 2. Aim at further developments and plan for the future. In firmly upholding the philosophies of strategic management, investment for greater development, solid and thorough implementation of park and project construction as well as scientific R&D, the Group will summarize and learn from the experience and shortcomings in the first half of 2011. The Group will put in place various tasks for the second half of the year so as to prepare for the deployment next year and facilitate the accomplishment of the "12th Five-year Plan" objectives. By stepping up merger & acquisition efforts, the Company speeded up corporate expansion. Through introducing new products to support corporate growth, the Company aspires to accomplish its business deployment as soon as possible.3. Increased efforts in scientific research and innovation to sustain growth momentum. In the second half of the year, the Company will continue to deploy 8 to 10 research projects and complete 13 pilot production projects, so as to reinforce potential for the Company's future development. It will, through technical innovation, strive to lower consumption and costs, reduce pollutant discharge and improve product technology and economic benefits while accomplishing the technology projects as planned at the beginning of the year to substantially reduce the production costs of a number of pharmaceutical products. Furthermore, it will step up efforts in promoting the Four New technologies and the application of new energy-efficient technologies such as MVR, thus ensuring the fulfillment of its energy conservation targets for the whole year.4. Vigorously promote management innovation. Viewing reform and innovation as the permanent theme for corporate development and adhering to the principle of trouble shooting in corporate development, the Group will make appropriate adjustments to corporate systems, mechanisms and organizational structure to adapt to ever-changing situations and enhance synergy efficiency. 5. Enhance the overall quality of staff. The Group will optimize the performance assessment system, strengthen the implementation of performance and quantified assessments, enhance the overall quality of mid- and high-level managements, and cultivate a strong and competent team for the further growth of the Company.VI. MANAGEMENT DISCUSSION AND ANALYSISThe Group is mainly engaged in the development, manufacturing and sale of bulk pharmaceuticals, pharmaceutical preparations, chemicals and other products. The profit of the Group is mainly attributable to these businesses.1. LIQUIDITY AND ANALYSIS OF FINANCIAL RESOURCES AND CAPITAL STRUCTURE UNDER HKGAAPAs of 30 June 2011, the liquidity ratio of the Group was 186.00%, the quick ratio was 128.29%, the turnover ratio of account receivables was 441.61% (turnover ratio of account receivables = turnover / average account receivables and net value of bills x 100%) and the turnover ratio of inventory was 320.65% (inventory turnover ratio = cost of sales / average net value of inventory x 100%).There was no significant seasonal effect on the capital demand of the Group.The main source of funds for the Group was loans from financial institutions. As at 30 June 2011, the total amount of bank loans was approximately RMB594,949,000, which was floating rate loans and was accounted by HIBOR and rates issued by Bank of China. As at 30 June 2011, cash on hand and in bank amounted to approximately RMB371,374,000 (including bank acceptance drafts deposits of approximately RMB13,000,000).During the Reporting Period, the Groupcharged the land use rights in Hutianzhen,Zhangdian,to a bankforloans. Thebook valueof the land use rightsis RMB70,306,000.There was no charge on the Groups assets except the above charged assets.The Group has stringent internal control systems for cash and fund management in order to strengthen financial management. The Group has sound liquidity and repayment ability.The Group did not have any significant investment, acquisitions or asset disposals during this reporting period.The clarification of the performance results of the Group is referred to in the section headed Results and Financial Analysis under PRC accounting standards.As at 30 June 2011, the number of employees of the Group was 5,711. The total salaries for employees in the first half of 2011 amounted to RMB106,414,000.The main investment projects in the second half of 2011 will be Hutian Park project and Shouguang Park project.As at 30 June 2011, the capital debt ratio of the Group was 34.55% (capital debt ratio = total borrowings / equity attributable to owners of the Company x 100%).The cash and bank balances of the Company will mainly be used as working capital for production, operation, projects and research development.The assets and debts of the Group were denominated in Renminbi. However, the Group achieved USD90,008,000 in its export for the first half of 2011. Therefore, there was a greater impact from foreign exchange. The Group adopted the following measures to minimise the foreign exchange fluctuation risk: 1. raising the export price in order to minimise foreign exchange fluctuation risk; and 2. when the Group enters into an export contract involving large quantities of products with other parties, the Group shall seek prior consent from the other party that both parties will bear the foreign exchange fluctuation risk should the foreign exchange fluctuation exceed the contractual limit as agreed by both parties.2. RESULTS AND FINANCIAL ANALYSIS UNDER PRC ACCOUNTING STANDARDSIn the first half of 2011, the Group had achieved a turnover of RMB1,522,812,000, representing an increase of 11.27% as compared to the same period last year. The increase in revenue was mainly attributable to the Companys export sales for the period growing by 21.37% and sales of chemical products posting a twofold year-on-year increase over the same period last year. The decrease in net cash and cash equivalents was RMB9,696,000, while there was an increase of RMB47,131,000 in the same period last year. The main reason for the change was that the decrease in net cash outflow from operating activities was RMB109,470,000 as compared to the same period last year. Operating profit amounted to RMB79,497,000, representing an increase of11.75% as compared to the same period last year. The main reason for the increase was that the Group actively expanded new markets and the leading products sales increased. At the same time it controlled purchase costs, reduced the consumption of raw materials and power and increased the product gross profit margin.Total assets of the Group as at 30 June 2011 amounted to RMB2,852,288,000, representing an increase of RMB112,723,000 or 4.11% as compared to the figure of RMB2,739,565,000 as at 1 January 2011. This increase was mainly due to an increase in construction in progress during the Reporting Period. The Groups bank loans as at 30 June 2011 was RMB594,949,000, representing an increase of RMB119,421,000 from RMB475,528,000 at the beginning of this year. Such increase was attributable to cash borrowed by the Company from the bank to ensure supply of funds for production and projects construction. The Company has obtained part of the loan during the reporting period. Total equity attributable to equity holders of the Company as at 30 June 2011 overall increased by RMB36,495,000 or 2.18%, from RMB1,676,524,000 at the beginning of this year to RMB1,713,019,000. This change was mainly attributable to (1) an increase of RMB60,702,000 from the operating profit of the Group during the Reporting Period; and (2) a deduction of RMB22,866,000 for the distribution of 2010 annual cash dividend.An analysis of the Groups turnover from principal operations is as follows (RMB000):By geographical location of customersFirst half of 2011First half of 2010Total turnoverCostsTotal turnoverCostsPRC (incl. Hong Kong)927,985732,016881,518721,942Europe224,577184,257166,175127,086Americas267,315244,426243,950203,246Others81,68470,98452,74939,509Total1,501,5611,231,6831,344,3921,091,783By industry and By productIncome from principal operationsCosts of sales of principal operationsGross profit margin(%)Bulk pharmaceutical805,140666,022 17.28 Preparations270,361167,838 37.92 Medical commercial logistics358,687342,084 4.63 Chemical products and other products67,37355,739 17.27 Total1,501,5611,231,683 17.97 An analysis of profit as compared to 2010 is as follows:ItemsAmount (RMB000)% of total profitJan.-Jun. 20112010Jan.-Jun. 20112010Operating profit 79,497  131,702  102.55  105.25 Profit/Loss from non-operation activities(1,979)(6,574)(2.55)(5.25)Profit before taxation 77,518  125,128  100.00  100.00 3. USE OF PROCEEDSOn 3 September 2001, the Company raised an amount of RMB370,517,000 from the public offer and issue of 33,000,000 A Shares (including the sale of 3,000,000 State-owned shares). As at 30 June 2011, RMB363,319,000 were used in the following projects: Name of projectPlanned investmentRMB000Actual investment Jan.-Jun. 2010RMB000Accumulated amount of investmentRMB000% of the investmentRemarksState-level technical center renovation74,50088825,18533.81%-Injection GMP renovation80,000-80,226100.28%completedCaffeine technical renovation160,000-188,201117.63%completedL-350 technical renovation29,980-23,44278.19%completedAnalgin GMP renovation39,800-46,265116.24%completedTotal384,280888363,319--(1) Injection GMP renovation project did not reach its profit forecast due to the decrease in pharmaceutical prices.(2) Caffeine technical renovation did not reach its profit forecast because of the effects of the drop in the price and the export tax rebate rate.(3) The principal part of the project of renovation of the state-level technical center has been completed.The remaining proceeds were deposited with banks and will be used in accordance with the Companys project commitments.VII. REVIEW OF MAJOR EVENTSSave as disclosed herein:1. There is no material deviation between the actual corporate governance implemented by the Company and the rules and requirements of corporate governance required to be observed by listed companies in the PRC.2. The Board did not recommend the payment of any interim dividend, nor any transfer from reserves to share capital, for the year 2011.3. The Group was not involved in any material litigation or arbitration, whether pending or threatened during the reporting period.4. There was no material purchase of assets or disposal of the Companys assets, nor did any material mergers or acquisitions involving the Company occur during the Reporting Period. Similarly, no transactions of such nature occurred during the last reporting period and were carried over to the Reporting Period.5. During the Reporting Period, there was no trust, subcontract and lease of the assets between the Company and other companies.6. The independent non-executive directors special explanation and independent opinions in respect of the use of funds by related parties and external security provided are as follows:During the Reporting Period, there was no non-operational use of the Companys funds by the controlling shareholder and other related parties.During the Reporting Period, there was no material guarantee provided by the Company, nor has there been any obligations that have not been performed in full by the Company. There were no guarantees provided by any controlling shareholders, non-legal entity or individuals which were prejudicial to the interests of the Company and the shareholders, in particular the minority shareholders, of the Company. As at 30 June 2011, the Company had no overdue external guarantee debts and the Company had no liability arising from any guarantee due to the default of a guaranteed party.7. The Company and its shareholders holding more than 5% of total number of issued shares of the Company have provided undertakings for information disclosure as follows: Nil8. Purchase, Sales and Redemption of the Companys listed securitiesDuring the Reporting Period, neither the Company nor its subsidiaries purchased, sold or redeemed any of its securities.9. Management of FundsDuring the Reporting Period, the Company did not appoint any person to manage the Companys funds. No such appointment was made in the preceding reporting period and carried over to the Reporting Period.10. Information about holding other listed companies (RMB)Stock CodeAbbreviated NameInitial investment amountProportion of equity interest in investeeBook value of end of the Reporting PeriodProfit/loss in the Reporting PeriodChange of shareholders equity in the Reporting PeriodAccounting coursesShare source601601China Pacific Insurance7,000,000.000.06%111,950,000.001,750,000.00(2,550,000.00)Available-for-sale financial assetsPurchase601328BANKCOMM14,225,318.000.02%41,394,880.00-448,320.00Available-for-sale financial assetsPurchaseTotal21,225,318.00-153,344,880.001,750,000.00(2,101,680.00)-11. Index of important information which has been disclosedThe announcement of the 2010 Annual Results Announcement was published on the HKExnews, in the Securities Times in the PRC, on the website: http://www.cninfo.com.cn and on the Companys website on 21 March 2011.The announcement of the The First Quarter Report of 2011 was published on the HKExnews, in the Securities Times in the PRC, on the website: http://www.cninfo.com.cn and on the Companys website on 29 April 2011.The announcement of the The Notice of Annual General Meeting for the 2010 was published on the HKExnews, in the Securities Times in the PRC, on the website: http://www.cninfo.com.cn and on the Companys website on 12 May 2011.The announcement of the Announcement of 2010 Annual General Meeting Resolutions was published on the HKExnews, in the Securities Times in the PRC, on the website: http:// www.cninfo.com.cn and on the Companys website on 29 June 2011.12. Information of reception research, communication and interview during the Reporting PeriodReception timeReception locationReception methodReception objectsMain content of the discussion and the information provided24 May 2011Office address of the CompanyField studyGuosen Securities (HK) Financial Holdings Company LimitedUnderstand the basic information and the prospect of the Companys developmentVIII. CORPORATE GOVERNANCECOMPLIANCE WITH THE CODE ON CORPORATE GOVERNANCE PRACTICESThe Directors confirmed that the Company was in compliance with the Code on Corporate Governance Practices (the Code) and has not deviated from the Code during the six months ended 30 June 2011. The Code includes the provisions contained in Appendix 14 to the Listing Rules.AUDIT COMMITTEEThe Company set up the audit committee under the Board in accordance with Rule 3.21 of the Listing Rules.The audit committee along with the management of the Company has reviewed the accounting standards, principles and methods adopted by the Group, and considered matters regarding auditing, internal control and financial reporting including the unaudited interim accounts for the six months ended 30 June 2011.The audit committee agreed to the accounting standards, principles and methods adopted by the Group for the unaudited interim accounts for the six months ended 30 June 2011, and it has been disclosed fully.INDEPENDENT NON-EXECUTIVE DIRECTORThe Company has complied with Rules 3.10(1) and 3.10(2) of the Listing Rules relating to the appointment of a sufficient number of independent non-executive directors and at least one independent non-executive director with appropriate professional qualifications, or accounting or related financial management expertise. The Company has appointed three independent non-executive directors including one with financial management expertise; details of their biographies were set out in the 2010 Annual Report of the Company.MODEL CODE FOR SECURITIES TRANSACTIONS BY DIRECTORS OF LISTED ISSUERS (MODEL CODE)During the Reporting Period, the Company has adopted a code of conduct regarding transactions by Directors on terms no less exacting than the required standards set out in the Model Code. After having made specific enquiries to the Directors and Supervisors, the Company has confirmed that during the Reporting Period, all Directors and Supervisors have complied with the required standard set out in the Model Code in relation to directors securities transactions and they did not have any non-compliance with the Mode Code. h!. FINANCIAL REPORTS1. Profit and loss account prepared in conformity with PRC accounting standards (Unaudited) Unit: RMBItem First half of 2011First half of 20100ConsolidatedParent companyConsolidatedParent company1.Total operating income1,522,811,524.54957,937,694.811,368,618,869.54919,627,165.93 Includes: Operating income1,522,811,524.54957,937,694.811,368,618,869.54919,627,165.932.Total operating costs1,448,271,735.29928,194,170.011,301,110,155.78868,429,433.07 Includes: Operating cost1,254,708,252.89831,515,794.471,117,047,193.39740,266,357.99 Taxes and surcharges5,697,453.843,781,025.987,349,609.916,390,089.53 Selling expenses91,559,028.3612,187,415.3189,541,312.7145,366,864.74 Administrative expenses78,262,015.0864,859,815.9177,263,090.2165,903,825.12 Financial expenses16,245,648.3215,850,118.349,908,949.5610,502,295.69 Assets Impairment loss1,799,336.80--- Add: Gain or loss from changes in fair value---- Investment gain or loss4,956,897.334,950,963.063,632,194.937,173,643.44 Includes: Investment gain or loss from related ventures and joint ventures3,200,963.063,200,963.062,822,345.262,822,345.26 Exchange gain or loss----3. Operating profit79,496,686.5834,694,487.8671,140,908.6958,371,376.30 Add: Non-operating income778,974.27756,432.665,524,758.331,408,050.15 Less: Non-operating cost2,757,720.092,220,925.971,685,159.501,591,481.52 Includes: Loss from the disposal of non-current assets539,620.93539,620.93153,790.74153,790.744. Profit before taxation77,517,940.7633,229,994.5574,980,507.5258,187,944.93 Less: Income tax expense15,417,765.134,476,899.9614,050,412.219,064,482.145. Profit after taxation62,100,175.6328,753,094.5960,930,095.3149,123,462.79 Includes: Profit attributable to the equity holders of the parent company60,702,135.8328,753,094.5957,881,893.6349,123,462.79 Minority interest1,398,039.80-3,048,201.68-6. Earnings per share 1) Basic earnings per share0.130.060.130.11 2) Diluted earnings per share0.130.060.130.117.Other comprehensive income(1,101,638.62)(1,786,428.00)(31,444,742.13)(30,179,101.05)8. Total comprehensive income60,998,537.0126,966,666.5929,485,353.1818,944,361.74 Includes: Total comprehensive income attributable to the equity holders of the parent company59,360,820.9326,966,666.5926,880,125.8818,944,361.74 Total comprehensive income attributable to the minority interest1,637,716.08-2,605,227.30-NOTES:xe "s, 1. compared with the latest annual reportA th"1. During the Reporting Period, there was no change in accounting policies and accounting estimates.xe "nfluences, 2. in the range of consolidation as co"2. During the Reporting Period, there was no change in the scope consolidated financial statements of the Company.2. FINANCIAL STATEMENTS PREPARED UNDER HKGAAPCondensed consolidated income statementNotesSix months ended 30 June20112010RMB000RMB000(unaudited)(unaudited)Revenue31,509,0291,352,583Cost of sales(1,237,382)(1,099,135)Gross profit271,647253,448Investment income2,7321,641Other income21,54810,754Other gains and losses(5,426)(820)Distribution and selling expenses(99,027)(97,732)Administrative expenses(82,808)(79,423)Other expenses(23,463)(5,494)Share of profit of an associate3,2012,822Finance costs(11,640)(8,070)Profit before tax476,76477,126Income tax expense5(15,305)(13,904)Profit for the half-year61,45963,222Profit for the half-year attributable to:Owners of the Company60,06160,174Non-controlling interests1,3983,04861,45963,222Earnings per share - basic and diluted 6RMB0.131RMB0.132Condensed consolidated statement of comprehensive incomeSix months ended 30 June20112010RMB000RMB000(unaudited)(unaudited)Profit for the half-year61,45963,222Other comprehensive income (expenses):Exchange differences arising on translation 685(1,266)Fair value loss on available-for-sale financial assets (2,101)(39,175)Income tax relating to components of other comprehensive income 3145,876Other comprehensive expenses for the half-year, net of tax(1,102)(34,565)Total comprehensive income for the half-year60,35728,657Total comprehensive income attributable to:Owners of the Company58,71926,051Non-controlling interests1,6382,60660,35728,657 Condensed consolidated statement of financial positionNotes30 June 201131 December 2010RMB000RMB000(unaudited)(audited)Non-current assetsTechnical know-how--Property, plant and equipment988,1771,007,323Construction in progress222,900120,261Prepaid lease payments on land use rights219,909222,703Investment properties38,77135,707Interest in an associate19,82116,620Available-for-sale investments156,545158,646Deferred tax assets3,3503,418 Prepayments for acquisition of land use rights12,9529,6521,662,4251,574,330Current assetsInventories370,243401,543Trade and other receivables8432,030375,963Prepaid lease payments on land use rights5,6905,741Amount due from an associate108-Amounts due from fellow subsidiaries-37Tax recoverable8821,289Pledged bank deposits13,00035,980Bank balances and cash358,374368,0701,180,3271,188,623Assets classified as held for sale12,8469,6461,193,1731,198,269Current liabilitiesTrade and other payables9429,927503,914Amounts due to fellow subsidiaries5,5386,087Amount due to an associate-2Tax payable6,0193,061Borrowings200,000200,000641,484713,064Liabilities associated with assets classified as held for sale-1,166641,484714,230Net current assets551,689484,039Total assets less current liabilities2,214,1142,058,369Capital and reservesShare capital457,313457,313Reserves1,264,7621,206,043Proposed final dividend-22,866Equity attributable to owners of the Company1,722,0751,686,222Non-controlling interests39,64838,010Total equity1,761,7231,724,232Non-current liabilitiesDeferred tax liabilities2,4422,871Borrowings394,949275,528Deferred income55,00055,738452,391334,1372,214,1142,058,369NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS UNDER HKGAAP1. Basis of preparation The Groups unaudited condensed interim financial information has been prepared in accordance with the applicable disclosure provisions of Appendix 16 to the Listing Rules and with Hong Kong Accounting Standard (HKAS) 34, Interim Financial Reporting, issued by the Hong Kong Institute of Certified Public Accountants (HKICPA). The unaudited condensed consolidated interim financial information should be read in conjunction with the annual financial statements for the year ended 31 December 2010.Principal accounting policies The consolidated condensed interim financial information has been prepared on the historical cost basis except for property, plant and equipments and certain financial instruments, which are measured at revalued amounts or fair values, as appropriate. Historical cost is generally based on the fair value of the consideration given in exchange for assets.The accounting policies used in the consolidated condensed interim financial information are consistent with those followed in the preparation of the Groups annual financial statements for the year ended 31 December 2010, except as described below.In the current year, the Group has applied the following new and revised standards, amendments and interpretations (Int) (new and revised HKFRSs) issued by the HKICPA.HKFRSs (Amendments)Improvements to HKFRSs 2010 except for the amendments to HKFRS 3 (Revised in 2008), HKFRS 7, HKAS 1 and HKAS 28HKFRS 1 (Amendment)Limited Exemptions from Comparative HKFRS 7 Disclosures for First-time AdoptersHKAS 24 (Revised)Related Party DisclosuresHKAS 32 (Amendment)Classification of Rights IssuesHK(IFRIC) - Int 14 (Amendment)Prepayments of a Minimum Funding RequirementHK(IFRIC) - Int 19Extinguishing Financial Liabilities with Equity InstrumentsThe Group has not early applied the following new and revised standards, amendments or interpretations that have been issued but are not yet effective.HKFRS 1 (Amendment)Severe Hyperinflation and Removal of Fixed Dates for First-time Adopters1HKFRS 7 (Amendments)Disclosures Transfers of Financial Assets1HKFRS 9Financial Instruments4HKFRS 10Consolidated Financial Statements4HKFRS 11Joint Arrangements4HKFRS 12Disclosure of Interests in Other Entities4HKFRS 13Fair Value Measurement4HKAS 1 (Revised)Presentation of Financial Statements3HKAS 12 (Amendment)Deferred Tax: Recovery of Underlying Assets2HKAS 19 (2011)Employee Benefits4HKAS 27 (2011)Separate Financial Statements4HKAS 28 (2011)Investments in Associates and Joint Ventures41 Effective for annual periods beginning on or after 1 July 2011.2 Effective for annual periods beginning on or after 1 January 2012.3 Effective for annual periods beginning on or after 1 July 2012.4 Effective for annual periods beginning on or after 1 January 2013.HKFRS 9 Financial Instruments issued in November 2009 and amended in October 2010 introduces new requirements for the classification and measurement of financial assets and financial liabilities and for derecognition.HKFRS 9 requires all recognised financial assets that are within the scope of HKAS 39 Financial Instruments: Recognition and Measurement to be subsequently measured at amortised cost or fair value. Specifically, debt investments that are held within a business model whose objective is to collect the contractual cash flows, and that have contractual cash flows that are solely payments of principal and interest on the principal outstanding are generally measured at amortised cost at the end of subsequent accounting periods. All other debt investments and equity investments are measured at their fair values at the end of subsequent accounting periods.The most significant effect of HKFRS 9 regarding the classification and measurement of financial liabilities relates to the accounting for changes in fair value of a financial liability (designated as at fair value through profit or loss) attributable to changes in the credit risk of that liability. Specifically, under HKFRS 9, for financial liabilities that are designated as at fair value through profit or loss, the amount of change in the fair value of the financial liability that is attributable to changes in the credit risk of that liability is recognised in other comprehensive income, unless the recognition of the effects of changes in the liabilitys credit risk in other comprehensive income would create or enlarge an accounting mismatch in profit or loss. Changes in fair value attributable to a financial liabilitys credit risk are not subsequently reclassified to profit or loss. Previously, under HKAS 39, the entire amount of the change in the fair value of the financial liability designated as at fair value through profit or loss was recognised in profit or loss.HKFRS 9 is effective for annual periods beginning on or after 1 January 2013, with earlier application permitted.The directors anticipate that HKFRS 9 that will be adopted in the Groups consolidated financial statements for the annual period beginning 1 January 2013 and that the application of the new standard will have a significant impact on amounts reported in respect of the Groups financial assets and financial liabilities. However, it is not practicable to provide a reasonable estimate of that effect until a detailed review has been completed.The amendments to HKFRS 7 titled Disclosures Transfers of Financial Assets increase the disclosure requirements for transactions involving transfers of financial assets. These amendments are intended to provide greater transparency around risk exposures when a financial asset is transferred but the transferor retains some level of continuing exposure in the asset. The amendments also require disclosures where transfers of financial assets are not evenly distributed throughout the period. To date, the Group has not entered into transactions involving transfers of financial assets. However, if the Group does enter into any such transactions in the future, disclosures regarding those transfers may be affected.The directors of the Company anticipate that the application of other new and revised standards, amendments or interpretations will have no material impact on the results and the financial position of the Group.3. Segment informationDescription of segmentsManagement has determined the operating segments based on the internal reports reviewed by the chief operating decision maker for the purpose of allocating resources to segments and assessing their performance. The Groups operating and reportable segments are as follows:Bulk pharmaceuticals:Development, production and sales of bulk pharmaceuticalsPreparations:Development, production and sales of preparations (e.g. tablets and injections)Commerce circulations:Trading of pharmaceutical products (including retail and wholesale)Chemical and other products:Production and sales of chemical and other products Information regarding the above segments is reported below: Segment turnover and results The following is an analysis of the Group s turnover and results by reportable segment.For the six months ended 30 June 2011Unaudited Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other products EliminationsTotalRMB000RMB000RMB000RMB000RMB000RMB000REVENUE External sales812,608270,361358,68767,373-1,509,029Inter-segment sales4,272160,38543,388154,751(362,796)-Total 816,880430,746402,075222,124(362,796)1,509,029Segment profit59,21022,1094,1294,36489,812Investment and other income 24,280Other gains and losses(5,426)Other expenses(23,463)Finance costs(11,640)Share of profit of an associate3,201Profit before tax 76,764For the six months ended 30 June 2010Unaudited Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other products EliminationsTotalRMB000RMB000RMB000RMB000RMB000RMB000REVENUE External sales740,382255,126329,30627,769-1,352,583Inter-segment sales2,034183,11942,83290,752(318,737)-Total 742,416438,245372,138118,521(318,737)1,352,583Segment profit 47,48919,9725,7163,11676,293Investment and other income12,395Other gains and losses(820)Other expenses(5,494)Finance costs(8,070)Share of profit of an associate2,822Profit before tax 77,126The accounting policies of the reportable segments are the same as the Groups accounting policies. Segment profit represents the profit earned by each segment without allocation of investment and other income, other gains and losses, other expenses, finance costs and share of profit of an associate. This is the measure reported to the chief operating decision maker for the purposes of resource allocation and performance assessment. Inter-segment sales are charged at prevailing market rates.Segment assetsThe following is an analysis of the Group s assets by reportable segment.At 30 June 2011Unaudited Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other products TotalRMB 000RMB 000RMB 000RMB 000RMB 000Segment assets1,204,768456,206168,776422,2592,252,009Unallocated corporate assets603,589Consolidated assets2,855,598At 31 December 2010Audited Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other products TotalRMB 000RMB 000RMB 000RMB 000RMB 000Segment assets1,244,040428,056128,777342,3502,143,223Unallocated corporate assets629,376Consolidated assets 2,772,599For the purposes of monitoring segment performances and allocating resources among segments: all assets are allocated to reportable segments other than deferred tax assets, interest in an associate, assets classified as held for sale, available-for-sale investments, investment properties, tax recoverable, pledged bank deposits and bank balances and cash. Assets used jointly by reportable segments are allocated on the basis of revenues earned by individual reportable segments.4. Profits before taxProfit before tax has been arrived at after charging (crediting):Six months ended 30 June20112010RMB000RMB000(unaudited)(unaudited)Interest on borrowings11,6408,070Amortisation of prepaid lease payments on land use rights2,8452,891Amortisation of technical know-how-117Depreciation for property, plant and equipment61,54458,733Depreciation for investment properties1,6281,361Cost of inventories recognised as an expense1,237,3821,099,135Dividends and interest income(2,732)(1,641)Loss (gain) on disposal of property, plant and equipment57(794)5. Income tax expenseThe major components of income tax expense in the condensed income statement are:Six months ended 30 June20112010RMB000RMB000(unaudited)(unaudited) Current income tax PRC Enterprise Income Tax (EIT)15,35014,050Deferred income tax(45)(146)Income tax expense15,30513,904Under the Law of the PRC on Enterprise Income Tax (the EIT Law) and Implementation Regulation of the EIT Law, the tax rate of the PRC companies is 25% from 1 January 2008 onwards. Pursuant to the relevant laws and regulations in the PRC, the Company was accredited as a high-tech enterprise. The accreditation is valid for three years. The Company is entitled to the preferential tax rate of 15% for a three-year period commencing from 1 January 2008 to 31 December 2010.Pursuant to the relevant laws and regulations in the PRC, two subsidiaries operating in the PRC are entitled to exemption from the PRC income tax in the first two years from the first profit-making year, followed by a 50% reduction of the PRC income tax for the next three years.6. Earnings per shareThe calculation of the basic earnings per share is based on the Groups profit attributable to the owners of the Company of RMB60,061,000 (2010: RMB60,174,000) and based on the weighted average of 457,312,830 shares (2010 : 457,312,830 shares) in issue during the period.Basic earnings per share and diluted earnings per share for the six months ended 30 June 2011 and 2010 are the same as there were no dilutive events existed during both periods.7. Dividends(a) The board of the directors of the Company did not recommend the payment of an interim dividend for the six months ended 30 June 2011 (2010: Nil).(b) Dividends attributable to the previous financial year, approved during the interim period.Six months ended 30 June20112010RMB000RMB000(unaudited)(unaudited) Final dividend in respect of the financial year ended 31 December 2010, approved during the following interim period, of RMB0.05 per share (year ended 31 December 2009: RMB0.05 per share)22,86622,8668. Trade and other receivables30 June 201131 December 2010RMB000RMB000(unaudited)(audited) Trade and bills receivables379,148308,235Less : Allowance for doubtful debts of trade receivables(1,984)(1,979)377,164306,256Other receivables, deposits and prepayments63,72178,835Less : Allowance for doubtful debts of other receivables(8,855)(9,128)54,86669,707Total trade and other receivables432,030375,963Included in the trade and bills receivables are debtors and bills receivables, net of allowance for bad debt and doubtful debts, with the following ageing analysis:30 June 201131 December 2010RMB000RMB000(unaudited)(audited) Within one year376,274303,310More than one year but less than two years7442,601-p r s t   x z ~ ιΦ}jT94h'hB*CJOJPJQJaJnHo(phtH+hbc]hCJOJPJQJaJnHo(tH%hCJOJPJQJaJnHo(tHhCJQJaJo(h5CJQJaJo( h5CJQJaJnHo(tH$h5CJPJQJaJnHo(tH(jh5CJQJUmHnHo(uh5CJQJo(h5CJOJQJh6KHOJPJQJ]h6KHOJQJ]q r s u v  x 2 X /0GH  $v dWD`v a$$da$^ $dT^a$$a$)O 2 X \ ^ ` b p   H O P ְs`ZQZQZH*B*CJOJQJ^JaJphhU4h0J.B*CJphjhU4hCJUjhU4hCJUjhU4hCJU hU4hCJOJQJ^JaJhU4hCJPJnHo(tHhU4hCJhU4hCJo()o 8:JLTV@BHxlhU4h5CJaJ&hU4h5CJPJaJnHo(tHhU4h5hU4h5o(+hU4hCJOJPJQJaJnHo(tHhU4h5CJ\hU4hCJo(hU4hCJPJnHo(tHjhU4hCJUjhU4hCJUhU4hCJ$9:KLUV@BXl $$1$Ifa$$da$HJ $&024@BJLRT¨m_H7H7H7!hU4h5CJKH\aJo(-hU4h5CJKHPJ\aJnHo(tHhU4hCJKHaJo('hU4h&6CJKHPJaJnHo(tHhU4hCJKHaJ2hU4h&65CJKHOJPJQJaJnHo(tH2hU4h5CJKHOJPJQJaJnHo(tH#hU4h5CJKHOJQJaJ#hU4hCJPJaJnHo(tHhU4h5CJaJhU4h5CJaJo(TXlQRctyzҸҸҸ䫟tetS#hU4h`n5CJKHOJQJaJhU4h`nB*CJaJph'hU4h`nCJKHPJaJnHo(tHh#h`n5CJaJhU4h`nCJaJhU4h`n5CJaJhU4h`nCJKHaJ2hU4h5CJKHOJPJQJaJnHo(tH#hU4h5CJKHOJQJaJhU4hCJKHaJhU4hCJKHaJo( ~rrr $$Ifa$gd`n$1$Ifxkd$$Ifl\ (#  p(#644 lalRcty~rrr $$Ifa$gd`n$1$Ifxkd"$$Ifl\ (#  p(#644 lalyzxlll $$Ifa$gd`n-00$IfXDYDxkd$$Ifl\ (#  p(#644 lal~rrr $$Ifa$gd`n$1$Ifxkdr$$Ifl\ (#  p(#644 lalYe~sssss $$1$Ifa$$1$Ifxkd$$Ifl\ (#  p(#644 lal8:;@AFGRSVWYe~%3AFdzǥǔ}}ǥdzqfZqfZqfZh#h`n5CJaJhU4h`nCJaJhU4h`n5CJaJ-hU4h`n5CJKHPJ\aJnHo(tH!hU4h`n5CJKH\aJo(hU4h`nCJKHaJo('hU4h`nCJKHPJaJnHo(tHhU4h`nCJKHaJ#hU4h`n5CJKHOJQJaJ2hU4h`n5CJKHOJPJQJaJnHo(tH#~rrr $$Ifa$gd`n$1$Ifxkd$$Ifl\ (#  p(#644 lal~rrr $$Ifa$gd`n$1$Ifxkd^$$Ifl\ (#  p(#644 lal%3AF~rrr $$Ifa$gd`n$1$Ifxkd$$Ifl\ (#  p(#644 lalFG|~rrr $$Ifa$gd`n$1$Ifxkd$$Ifl\ (#  p(#644 lalFN{|016;=YZ_dfx:HW_ȼȼȼȼȄpȄpȼ&h#h`n5CJPJaJnHo(tH*h#h`n5CJPJQJaJnHo(tH'hU4hCJKHPJaJnHo(tHhU4h`nCJKHaJo(h#h`n5CJaJhU4h`nCJaJhU4h`n5CJaJ'hU4h`nCJKHPJaJnHo(tHhU4h`nCJKHaJ,~rrr $$Ifa$gd`n$1$IfxkdV $$Ifl\ (#  p(#644 lal16;=~rrr $$Ifa$gd`n$1$Ifxkd $$Ifl\ (#  p(#644 lal=>Z_df~rrr $$Ifa$gd`n$1$Ifxkd $$Ifl\ (#  p(#644 lalfg~rrd$$4$Ifa$gd`n $$Ifa$gd`n$1$IfxkdN $$Ifl\ (#  p(#644 lal~rrd$$4$Ifa$gd`n $$Ifa$gd`n$1$Ifxkd $$Ifl\ (#  p(#644 lal:HW_~rrr $$Ifa$gd`n$1$Ifxkd $$Ifl\ (#  p(#644 lal_`~rrr $$Ifa$gd`n$1$IfxkdF$$Ifl\ (#  p(#644 lal"ȻyyeVD9hU4hFCJaJ#hU4hFCJhmH nHsH tHhU4hFKHPJnHtH&hU4hF5B*CJ\aJo(ph#hU4hF5B*CJ\aJphhU4hFB*CJaJphhU4hB*CJaJph#hU4hCJPJaJnHo(tHhU4h`nCJKHaJh#h`n5CJaJhU4h`nCJaJhU4h`n5CJaJ'hU4h`nCJKHPJaJnHo(tHzm\F-$00$4$IfXDYDa$gd{/-00$IfXDYDgd{/ -00XDYDgdF -00XDYDxkd$$Ifl\ (#  p(#644 lal"C~maMw$00$IfXDYDa$gd{/ $$Ifa$gd{/w00$IfXDYDgd{/fkd$$IflF" U t6    44 la-$00$4$IfXDYD]a$gd{/"CD`a6AJT_egz{ # - 3 B C D ^ e ӿөӞӊӞxxөӞhӞhU4hFCJOJQJaJo(#hU4hua5CJhmH nHsH tH&hU4hua5CJhmH nHo(sH tHhU4hFCJaJ*hU4hFCJPJhmH nHo(sH tH'hU4hFCJPJhmH nHsH tH#hU4hFCJhmH nHsH tH hU4hF&hU4hFCJhmH nHo(sH tH(CD6Az{gw$00$IfXDYDa$gd{/ $$Ifa$gd{/w00$IfXDYDgd{/fkd$$IflF" U t6    44 laz{{gw$00$IfXDYDa$gd{/ $$Ifa$gd{/w00$IfXDYDgd{/fkd$$IflF" U t6    44 la3 B C {{ $$Ifa$gd{/w00$IfXDYDgd{/fkd$$IflF" U t6    44 laC D ^ e f yy $$Ifa$gd{/w00$IfXDYDgd{/hkd$$Ifl\F" U t6    44 lae f g q z 椵vhvhvh_vhUA&hU4hF5CJKHOJQJaJo(hU4hFCJo(hU4hFCJhU4hF5CJaJo(hU4hF5CJaJ#hU4hFCJPJaJnHo(tHhU4hFCJOJQJaJo( hU4hFCJKHaJnHtHhU4hFCJaJ&hU4hFCJhmH nHo(sH tH#hU4hFCJhmH nHsH tHhU4hFCJaJhU4hFCJOJQJaJf g z {{ $$Ifa$gd{/w00$IfXDYDgd{/fkd$$IflF" U t6    44 la $$Ifa$gd{/ $Ifgd{/fkd|$$IflF" U t6    44 la &"x"|pp $$Ifa$gd{/ $$Ifa$gd{/ $da$gdFgdFfkd$$IflF" U t6    44 la ""&"\"`"t"x"z""""""տq]J O6    44 la"""""$$1$Ifa$gdM $Ifgd{/ekd$$Ifl,F3 > O6    44 la"""""#$#&#8#J#L#v#x#######$$ $$$$,$ɶɶɶr`ShU4hMCJKHaJ#hU4hMCJKHaJnH o(tH hU4hM5CJKHaJ&hU4hM5CJKHaJnH o(tH 'hU4hMCJKHPJaJnHo(tHhU4hMCJKHaJo($hU4hFCJKHOJQJ^JaJhU4hFCJKHaJhU4hF5CJKHaJhU4hFCJKHaJhU4hFCJKHaJo("#&#8#J#$$1$Ifa$gdM $Ifgd{/ekdn$$Ifl,F3 > O6    44 laJ#L#x###$$1$Ifa$gdM $Ifgd{/ekd$$Ifl,F3 > O6    44 la##$$$ $$$$$,$vvvvvvvv$$1$Ifa$gd $IfVDKWDY^`gd{/ekdj$$Ifl,F3 > O6    44 la ,$.$b$n$z$||$$1$Ifa$gdM$IfVDx^gd{/ekd$$Ifl,F3 > O6    44 la,$.$b$n$z$|$~$$$$$$$ıqZF4#hU4hF5CJKHOJQJaJ&hU4hF5CJKHOJQJaJo(,hU4hFB*CJPJaJnHo(phtHhU4hF5CJaJo(&hU4hF5CJPJaJnHo(tHhU4hF5CJaJ#hU4hFCJPJaJnHo(tH$hU4hFCJKHOJQJ^JaJhU4hFCJKHaJhU4hF5CJKHaJhU4hFCJKHaJo($hU4hMCJKHOJQJ^JaJ z$|$~$$$$ %zRF: $$Ifa$gd{/ $$Ifa$gd{/(<TPL HD@< ^gdF $da$gdFTQ gdFekdf$$Ifl,F3 > O6    44 la$%%%% %H%N%^%b%d%|%~%%%%%%&&&$&-&誚|naSF9nSF9nSFhU4hFOJQJaJhU4hFCJKHaJhU4hF5CJKHaJhU4hFCJKHaJhU4hFCJKHaJo(hU4hFQJ(hU4hFCJKHOJPJQJnHtHhU4hFCJKHOJQJo(+hU4hFCJKHOJPJQJnHo(tH+hU4hF5CJKHOJPJQJnHtH"hU4hF5CJKHOJQJo(.hU4hF5CJKHOJPJQJnHo(tH %N%b%d%~%%%{{$$1$Ifa$gd{/ $Ifgd{/`kd$$IflF '!@ @  t!    4 la $$Ifa$gd{/%%%%&$$1$Ifa$gd{/ $Ifgd{/`kdW$$IflF '!@ @  t!    4 la&&&$&-&$$1$Ifa$gd{/ $Ifgd{/`kd$$IflF '!@ @  t!    4 la-&.&[&f&q&$$1$Ifa$gd{/ $Ifgd{/`kd=$$IflF '!@ @  t!    4 la-&.&K&L&Z&[&f&q&r&s&&&&&&&߾wcWK=h?@hF5CJKHaJhQrhF5CJaJhU4hFCJaJo(&hU4hF5CJPJaJnHo(tHhU4hF5CJaJo(hU4hF5CJaJ#hU4hFCJPJaJnHo(tHhU4hFCJKHaJhU4hF5CJKHaJ$hU4hFCJKHPJaJnHtHhU4hFCJKHaJo('hU4hFCJKHPJaJnHo(tHhU4hFOJQJaJq&r&s&&&&'"'G'Z'}}}}} $$Ifa$gd{/gdF $da$gdFgdF`kd$$IflF '!@ @  t!    4 la &''!'"'F'G'Y'Z'\'q'v'w'}'~'''''''''''Ƴo^MAh?@hF5CJaJ hU4hFCJPJaJnHtH hU4hFCJPJaJnHtH#h?@hF5CJPJaJnHtHhU4hFCJaJo(#hU4hFCJPJaJnHo(tH&h?@hF5CJPJaJnHo(tH$hU4hFCJOJQJaJnHtH'h?@hF5CJOJQJaJnHtHh?@hF5CJKHaJo(*h?@hF5CJKHPJaJnHo(tHZ'['\'q'''' $$Ifa$gd{/ $Ifgd{/`kd#$$If4F H&<<d&    4 af4''''''(vmaaaa $$Ifa$gd{/ $Ifgd{/kd$$If4rn H&d&4 af4'''((-(;(I(Z(k(l(((((((((((()))0)Z)\)^)k)m)o)p))))))))))Ť{i#hU4hFCJPJaJnHo(tH hU4hFCJPJaJnHtH/hU4hFCJOJPJQJ^JaJnHo(tH#hU4hFCJPJaJnHo(tHhU4hFCJOJQJaJ hU4hFCJPJaJnHtH$hU4hFCJOJQJaJnHtHh?@hF5CJaJhU4hFCJaJ)((-(;(I(Z(k({rffff $$Ifa$gd{/ $Ifgd{/kd9$$Ifrn H&d&4 ak(l(((({o7. $Ifgd{/7kdQ$$IfH&d&d&4 a $$Ifa$gd{/kd$$Ifrn H&d&4 a((((((((())of $Ifgd{/kd$$Ifrn H&d&4 a $$Ifa$gd{/ ))\)^)k)m)o){rffff $$Ifa$gd{/ $Ifgd{/kd5$$Ifrn H&d&4 ao)p)))))){rffff $$Ifa$gd{/ $Ifgd{/kd$$Ifrn H&d&4 a)))=*>*b+c+H,I,J,K,{vnnbbbYYY $7$8$H$a$ $7$8$H$a$gdF$a$gdFgdFkdM$$Ifrn H&d&4 a )=*?*********++!+'+(+)+*+0+I+L+b+d+f+++++++++<,=,?,@,C,D,G,H,M,Q,\,_,`,,ݶѨ{shU4h5+hU4hCJOJQJ^JaJnHo(tHhU4hnHo(tHhU4hnHtHhU4hFPJnHo(tHhU4hFCJaJnHo(tHhU4hFCJaJhU4hFCJaJo(#hU4hFCJPJaJnHo(tH hU4hFCJPJaJnHtH-K,L,M,`,,,,,,,,$$If^a$ $If^7$8$H$$da$ $7$8$H$a$ ,,,,,,,,,,,,,,,,,,,,,ŷiQiiQiDhU4hOJQJaJ/hU4h&65B*CJPJaJnHo(phtH/hU4h5B*CJPJaJnHo(phtH hU4h5B*CJaJph%hU4hB*CJOJQJaJph#hU4hCJPJaJnHo(tHhU4h5CJaJo(hU4h5CJaJ9hU4h5CJKHOJPJQJ\^JaJnHo(tHhU4h5hU4h5o(,,,,-%->-[-uuuuu$$If^a$$$If^a$okd$$IfTl4TF "$  t1%6    44 laf4T,.-/-[-\-----------.1.2.9.A.B.r.s....../3/4/N/t/u/v//r](hU4hCJOJPJQJaJnHtH#hU4hCJPJaJnHo(tHhU4h&6nHo(tHhU4h&6OJQJ^J hU4h&6 hU4h&6OJQJ^JnHtHhU4h&6CJaJhU4h&6o(hU4hOJQJaJ/hU4h5B*CJPJaJnHo(phtH#hU4h5B*CJaJo(ph#[-\------i`QQQQ$d$Ifa$gd_ v$$Ifa$kdb$$IfTl4Tr ""$  t1%644 laf4T-------i`QQQQ$d$Ifa$gd_ v$$Ifa$kd$$IfTl4Tr ""$  t1%644 laf4T-------i`QQQQ$d$Ifa$gd_ v$$Ifa$kd$$IfTl4Tr ""$  t1%644 laf4T--..$.+.1.i^OOOO$d$Ifa$gd_ v$$G$Ifa$kd$$IfTl4Tr ""$  t1%644 laf4T1.2.9.;.=.?.A.i`QQQQ$d$Ifa$gd_ v$$Ifa$kdN $$IfTl4Tr ""$  t1%644 laf4TA.B.s.....i`QQQQ$d$Ifa$gd_ v$$Ifa$kd !$$IfTl4Tr ""$  t1%644 laf4T.......i`QQQQ$d$Ifa$gd_ v$$Ifa$kd!$$IfTl4r ""$  t1%644 laf4T..//!/-/3/i`QQQQ$d$Ifa$gd_ v$$Ifa$kdy"$$IfTl4Tr ""$  t1%644 laf4T3/4/N/Z/a/m/t/i`QQQQ$d$Ifa$gd_ v$$Ifa$kd.#$$IfTl4Tr ""$  t1%644 laf4Tt/u/v/000011E1iggg_g_gY^$da$kd#$$IfTl4Tr ""$  t1%644 laf4T ////000000,0-0.0U0V0W0X0[0\0i0j0t0u0v00000000Ծ闋wcUccUUUwUwcUhU4h5CJaJo(&hU4h&65CJPJaJnHo(tH&hU4h5CJPJaJnHo(tHhU4h5CJaJ#hU4hCJPJaJnHo(tH(hU4hua5CJOJPJQJaJnHtH+hU4hua5CJOJPJQJaJnHo(tH(hU4hCJOJPJQJaJnHtH+hU4hCJOJPJQJaJnHo(tH0000001171E1Z1[11111İĞr`O`O`7/hU4h5B*CJPJaJnHo(phtH hU4h5B*CJaJph#hU4h5B*CJaJo(ph(hU4hB*CJOJQJaJo(ph,hU4hB*CJPJaJnHo(phtH#hU4hCJPJaJnHo(tH&hU4h}~5CJPJaJnHo(tH&hU4h5CJPJaJnHo(tHhU4h5CJaJ5hU4h5CJOJPJQJ\^JaJnHo(tHE1[1q11111182^Ld$1$7$8$H$Ifgd_kd$$$IfTֈ ~4 T$ p T$aT$$If^a$111p2q2v2w222)3*373F3Z3[3g3h3w3333333333344"424C4D4L4[4m4n4o4444պկίկկկկկΝ}i&hU4h5CJPJaJnHo(tH&hU4h5CJPJaJnHo(tHhU4h5CJaJ#hU4hCJPJaJnHo(tHhU4hCJaJ'hU4h-CJKHPJaJnHo(tH hU4hhU4hCJKHaJ hU4h,hU4h5B*CJPJaJnHphtH)82Z2f2l2n2p2q22DkdW%$$IfTֈ ~4 T$ p T$aT$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_222222$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_22$kd&$$IfTֈ ~4 T$ p  <T$ap<T22 3333)3$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_)3*3$kdb'$$IfTֈ ~4 T$ p  <T$ap<T*373G3Q3V3X3Z3$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_"d$1$7$8$H$Ifgd_Z3[3$kd($$IfTֈ ~4 T$ p  <T$ap<T[3h3x33333$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_"d$1$7$8$H$Ifgd_33$kd)$$IfTֈ ~4 T$ p  <T$ap<T3333333$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_33$kdF+$$IfTֈ ~4 T$ p  <T$ap<T3333333$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_33$kd,$$IfTֈ ~4 T$ p  <T$ap<T334 4444$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_44$kd-$$IfTֈ ~4 T$ p  <T$ap<T4"424:4?4A4C4$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_C4D4$kd*/$$IfTֈ ~4 T$ p  <T$ap<TD4L4\4d4i4k4m4$d$1$7$8$H$Ifa$gdd$1$7$8$H$Ifgd_m4n4o4$"kdv0$$IfTֈ ~4 T$ p  <T$ap<T4444444;5<5N5W5X5p5}5555555555666&6/606E6N6O6c6l6m6666ѿxm`xmxmxmxxmxmxmxmxmhU4hCJKHaJhU4hOJQJhU4hCJaJhU4hCJKHaJhU4h5OJQJ#hU4h5B*CJaJo(ph hU4h5B*CJaJph#hU4hCJPJaJnHo(tH&hU4h5CJPJaJnHo(tHhU4h5CJaJo(hU4h5CJaJ%o4444+5;5<5B5N5W5{fW$d,$Ifa$gd_$d$1$7$8$H$Ifa$gd_d$1$7$8$H$Ifgd_]kd1$$IflFP" "    4 la $If^$da$ W5X5q5}55zk$d,$Ifa$gd_$d$1$7$8$H$Ifa$gd_d$1$7$8$H$Ifgd_]kd72$$IflFP" "    4 la55555zk$d,$Ifa$gd_$d$1$7$8$H$Ifa$gd_d$1$7$8$H$Ifgd_]kd2$$IflFP" "    4 la55555zk$d,$Ifa$gd_$d$1$7$8$H$Ifa$gd_"d$1$7$8$H$Ifgd_]kd-3$$IflFP" "    4 la55666zk$d,$Ifa$gd_$d$1$7$8$H$Ifa$gd_"d$1$7$8$H$Ifgd_]kd3$$IflFP" "    4 la666&6/6zk$d,$Ifa$gd_$d$1$7$8$H$Ifa$gd_d$1$7$8$H$Ifgd_]kd#4$$IflFP" "    4 la/606=6E6N6zk$d,$Ifa$gd_$d$1$7$8$H$Ifa$gd_d$1$7$8$H$Ifgd_]kd4$$IflFP" "    4 laN6O6[6c6l6zk$d,$Ifa$gd_$d$1$7$8$H$Ifa$gd_d$1$7$8$H$Ifgd_]kd5$$IflFP" "    4 lal6m6z666zk$d,$Ifa$gd_$d$1$7$8$H$Ifa$gd_d$1$7$8$H$Ifgd_]kd5$$IflFP" "    4 la66666zk$d,$Ifa$gd_$d$1$7$8$H$Ifa$gd_d$1$7$8$H$Ifgd_]kd6$$IflFP" "    4 la6666666667 7X7Y777777788A8B8x8y8888899S9T99999:: :":[:\::::::;;<;=;;¸¸¸¸¸¸®¸¸¸¸¸¸¸¸¸¸¸¸¸žžhU4hl&CJPJnHo(tHhU4hCJPJnHo(tHhU4h5CJhU4hCJo(hU4hCJ#hU4hCJPJaJnHo(tHhU4hOJQJhU4hCJaJhU4hCJKHaJ36666688!:":::::>>=>>>7$8$H$$da$]kd6$$IflFP" "    4 la;;;;;;;;==o=p=== >>><>=>>>?>j>k>z>{>>>>>>>ɶ묚kbM(hU4hB*CJOJQJaJo(phhU4h-CJ9hU4h5CJKHOJPJQJ\^JaJnHo(tHhU4h5o(hU4h5#hU4hCJPJaJnHo(tHhU4hCJo(%hU4h5CJPJ\nHo(tH"hU4h5CJPJ\nHtHhU4hCJPJnHo(tHhU4hCJhU4h5CJ\>>>>>>>?.?/?Rkd7$$Iflr4{"6m t64 la$If^gd7 $If^^$da$>>>>>>>>>>?????+?.?/?4?5?@?D?E?F?G?I?V?Ĺr_D_D4hU4hl&B*CJOJPJQJaJnHo(phtH%hU4hB*CJOJQJaJph(hU4hB*CJOJQJaJo(ph#hU4h5B*CJaJo(phhU4hOJQJ(hU4hB*CJOJQJaJo(phhU4hmOJQJ/hU4hm5B*CJPJaJnHo(phtH hU4hm5B*CJaJph#hU4hm5B*CJaJo(ph/?0?1?2?3?4?5?@?A?B?C?D?`kd7$$Iflr4{"6m t64 la $If^$$If^a$ D?E?W?`?d?h?l?wjj``` $If^$$If^a$kd_8$$Iflr4{"6m t64 laV?W?_?`?c?d?h?k?l?m?{?|???????????????ҽ|qҽҽ|qVCCV%hU4hl&B*CJOJQJaJph4hU4hl&B*CJOJPJQJaJnHo(phtHhU4hOJQJ+hU4h5B*CJOJQJaJo(ph+hU4hl&5B*CJOJQJaJo(ph(hU4hl&B*CJOJQJaJo(ph(hU4hB*CJOJQJaJo(ph%hU4hB*CJOJQJaJph4hU4hB*CJOJPJQJaJnHo(phtHl?m?|?????wjj``` $If^$$If^a$kd 9$$Iflr4{"6m t64 la????????wjZZMMM$If^gd_$$If^a$gdl&$$If^a$kd9$$Iflr4{"6m t64 la???@@0@4@8@<@wjjjj``` $If^$$If^a$kd]:$$Iflr4{"6m t64 la????@@/@4@7@8@<@=@H@^@`@d@g@h@l@m@z@@@@@@@@@@@@@@@@@@@AAAAAA9A\A`AcAdAhAiAmAnAoAͲ͜Ͳ͜Ͳ͜Ͳ͜Ͳ͜Ͳ͜͜hU4hl&OJQJnHtH+hU4hl&5B*CJOJQJaJo(ph4hU4hl&B*CJOJPJQJaJnHo(phtH(hU4hl&B*CJOJQJaJo(ph%hU4hl&B*CJOJQJaJphhU4hl&OJQJ6<@=@H@`@d@h@l@wjj``` $If^$$If^a$kd;$$Iflr4{"6m t64 lal@m@z@@@@@wjj``` $If^$$If^a$kd;$$Iflr4{"6m t64 la@@@@@@@wjj``` $If^$$If^a$kd[<$$Iflr4{"6m t64 la@@@AAAAwjj``` $If^$$If^a$kd=$$Iflr4{"6m t64 laAA9A\A`AdAhAwjj``` $If^$$If^a$kd=$$Iflr4{"6m t64 lahAiAjAkAlAmAnAwjj``` $If^$$If^a$kdY>$$Iflr4{"6m t64 lanAoA|A}A~AAAwjj``` $If^$$If^a$kd?$$Iflr4{"6m t64 laoA{A|AAAAAAAAAAAAAAAAAAAAAAABBBB B!B0B1BGBLBOBPBTBUBYBZB[BkBյյյյյյv hU4hl&5B*CJaJph4hU4hl&B*CJOJPJQJaJnHo(phtH%hU4hl&B*CJOJQJaJphhU4hl&OJQJ(hU4hl&B*CJOJQJaJo(ph+hU4hl&5B*CJOJQJaJo(ph(hU4hl&5B*CJOJQJaJph*AAAAAAAwjj]]]$If^gd_$$If^a$kd?$$Iflr4{"6m t64 laAAAAAAAwjj``` $If^$$If^a$kdW@$$Iflr4{"6m t64 laAAABBB Bwjj``` $If^$$If^a$kdA$$Iflr4{"6m t64 la B!B1BHBLBPBTBwjj``` $If^$$If^a$kdA$$Iflr4{"6m t64 laTBUBVBWBXBYBZBwjj`S`$$If^a$ $If^$$If^a$kdUB$$Iflr4{"6m t64 laZB[BlBmBnBoBpBwjj`S`$$If^a$ $If^$$If^a$kdB$$Iflr4{"6m t64 lakBlBoBpBqBuBBBBBBBBBBBBBBBBBBCCC C CCC.C0C1C8C9C:CpBpapbphpǹǹǹ|lll\hU4h@C%CJPJnHo(tHhU4hA$CJPJnHo(tHhU4h@uCJPJnHo(tHhU4hCJPJnHo(tH9hU4h5CJKHOJPJQJ\^JaJnHo(tHhU4h5CJaJo(hU4h5CJaJ3hU4hCJKHOJ PJQJ ^J aJnHo(tHhU4hCJo(hU4hCJ$hppppp qq&q*qkqlqmqqqqqqqq rrrrArBrVrarmrrrrrrrrrrrrrrrrr3s7sTsXsZsݬݜhU4hZ6CJPJnHo(tHhU4hZ6CJhU4hp"CJPJnHo(tHhU4hCJPJnHtH#hU4h@C%CJPJaJnHo(tHhU4h@uCJPJnHo(tHhU4hCJPJnHo(tHhU4hCJo(hU4hCJ0Zs[szs{sssssUtVtXttttttttGuHuhujuzu{u|uuuuuuuuuuvvvv#vξ{{khU4h2CJPJnHo(tHhU4h`(CJPJnHo(tHhU4h@uCJPJnHo(tHhU4hCJPJnHo(tHhU4hCJo(hU4hCJhU4hc!CJPJnHo(tHhU4hZ6CJo(hU4hZ6CJhU4hZ6CJPJnHo(tHhU4hZ6CJPJnHtH&tiujuvvvvwvwwwwuzvzzz~~"#z{ǃ $$1$Ifa$ $da$gd,%7$8$H$^ $da$gd2$da$#v*v;v=v>vtvuvvvvvvvvvvvvwwwwwzw{wwwwwwww x x xĴěĴěě{Ĵěk_h=2CJPJnHtHhU4h k`CJPJnHo(tHhU4hCJPJnHo(tHhU4hp"CJPJnHo(tHhU4hCJhU4h@uCJPJnHo(tHhU4hCJPJnHo(tHhU4hCJo(hU4h2CJPJnHtHhU4h2CJPJnHo(tHhU4h2CJo(hU4h2CJ! xxxx:x;xRSTVcfgjwz{~Ā$13hU4h,%CJo(hU4h,%CJPJnHo(tHhU4h,%CJ#hU4h,%CJPJaJnHo(tHhU4h,%CJaJL3Łǁȁҁ /1458CIehiԂՂ!"#nstxѿѿѿѿ墒xxhU4h5CJaJo(hU4h5CJaJhU4hCJPJnHo(tHhU4h,%CJnH o(tH hU4h,%CJPJnHtH#hU4h,%CJPJaJnHo(tHhU4h,%CJaJhU4h,%CJhU4h,%CJPJnHo(tHhU4h,%CJo(/xyz{ăƃǃųřgS?,$hU4hCJKHPJaJnHtH'hU4h@uCJKHPJaJnHo(tH'hU4hCJKHPJaJnHo(tH/hU4h5CJKHOJPJQJaJnHtH2hU4h@u5CJKHOJPJQJaJnHo(tH2hU4h5CJKHOJPJQJaJnHo(tH#hU4h5CJKHOJQJaJ&hU4h5CJKHOJQJaJo(hU4hQJ]o(hU4h5CJaJo(hU4h5CJaJ ǃȃɃ؃ރ $$1$Ifa$$1$IfhkdOH$$Ifl4?F  6    44 la]f4ǃȃɃ׃؃݃ރ *+2RS\|}τЄф 34JKL㻨yyynnbhU4hQJ]o(hU4h k`CJKHhU4h k`CJKHnHtHhU4h k`CJKHaJ$hU4h k`CJKHPJaJnHtH$hU4hCJKHPJaJnHtH'hU4hCJKHPJaJnHo(tH&hU4h5CJKHOJQJaJo(#hU4h5CJKHOJQJaJhU4hCJKH$ "*phZZZZ$$1$Ifa$gd_$1$IfkdH$$Ifl4?r)A644 la]f4*+2:BJRsk]]]]$$1$Ifa$gd_$1$IfkdUI$$Ifl?r)A644 la]RS\dlt|sk]]]]$$1$Ifa$gd_$1$IfkdI$$Ifl?r)A644 la]|}sk]]]]$$1$Ifa$gd_$1$IfkdUJ$$Ifl?r)A644 la]ńτsk]]]]$$1$Ifa$gd_$1$IfkdJ$$Ifl?r)A644 la]τЄф4Kse]RRR $$1$Ifa$$1$IfVDWD^`kdUK$$Ifl?r)A644 la]KL`hp~ppp$$1$Ifa$gd_$1$IfxkdK$$Ifl?\644 la]L_`υЅ89>?efgɆ|hVhVhVh#hU4h5CJKHOJQJaJ&hU4h5CJKHOJQJaJo(hU4hCJo(hU4h5CJaJo(&hU4h@u5CJPJaJnHo(tHhU4h5CJaJhU4hQJ]o(hU4h k`CJKHhU4h k`CJKHaJ$hU4h k`CJKHPJaJnHtH'hU4h k`CJKHPJaJnHo(tH!~ppp$$1$Ifa$gd_$1$IfxkdML$$Ifl?\644 la]Ѕ؅~ppp$$1$Ifa$gd_$1$IfxkdL$$Ifl?\644 la]&8~ppp$$1$Ifa$gd_$1$Ifxkd=M$$Ifl?\644 la]89?ISe~ppp$$1$Ifa$gd_$1$IfxkdM$$Ifl?\644 la]efgʆxppeee $$1$Ifa$$da$VDWD^`xkd-N$$Ifl?\644 la]Ɇʆˆ̆؆نچۆ݆߆ϻoU;"0hU4hCJKHOJPJQJ^JaJnHtH3hU4h@uCJKHOJPJQJ^JaJnHo(tH3hU4hCJKHOJPJQJ^JaJnHo(tH/hU4h5CJKHOJPJQJaJnHtH2hU4h@u5CJKHOJPJQJaJnHo(tH2hU4h5CJKHOJPJQJaJnHo(tH&hU4h5CJKHOJQJaJo($hU4hCJKHOJQJ^JaJhU4hCJKH#hU4h5CJKHOJQJaJ ʆˆ̆ۆ $$1$Ifa$$1$IfhkdN$$Ifl4?Fq && &  6    44 la]f4@Ajkۇ܇δvbOB7bOB7bOB7hU4h k`CJKHhU4h k`CJKHaJ$hU4h k`CJKHPJaJnHtH'hU4h k`CJKHPJaJnHo(tHhU4hCJKH0hU4hCJKHOJPJQJ^JaJnHtH3hU4h@uCJKHOJPJQJ^JaJnHo(tH3hU4hCJKHOJPJQJ^JaJnHo(tH/hU4h5CJKHOJPJQJaJnHtH2hU4h@u5CJKHOJPJQJaJnHo(tH$5@phZZZZ$$1$Ifa$gd k`$1$Ifkd&O$$Ifl4?rq &&&'& 644 la]f4@Aks{sk]]]]$$1$Ifa$gd k`$1$IfkdO$$Ifl?rq '''''' 644 la]Їۇsk]]]]$$1$Ifa$gd k`$1$IfkdP$$Ifl?rq '''''' 644 la]ۇ܇݇skkek_VVV $$Ifa$^7$8$H$$da$kdAQ$$Ifl?rq '''''' 644 la] ܇݇=>deĈňƈ߈׺wbN&hU4h5CJKHOJQJaJo((hU4hB*CJOJQJaJo(phhU4h k`CJPJnHo(tHhU4h@uCJPJnHo(tHhU4hCJPJnHo(tHhU4hCJo(hU4hCJ9hU4h5CJKHOJPJQJ\^JaJnHo(tHhU4h5CJaJo(hU4h5CJaJhU4hPJnHo(tH358;<de‰ÉʼnljɉʉٯyeyeS??&hU4hCJPJ\aJnHo(tH#hU4hCJPJ\aJnHtH&hU4hCJPJ\aJnHo(tH*hU4hCJPJQJ\aJnHo(tHhU4hCJ\aJ'hU4hCJKHPJaJnHo(tHhU4hOJQJ\nHtH2hU4h5CJKHOJPJQJaJnHo(tH&hU4h5CJKHOJQJaJo(#hU4h5CJKHOJQJaJ8@ai}^U $$Ifa$kdQ$$Iflֈh  ^"9U{!64 la $$Ifa$ljɉʉ^U $$Ifa$kdR$$Iflֈh  ^"9U{!64 la $$Ifa$ $,.6UL $$Ifa$kdeS$$Iflֈh  ^"9U{!64 la y$$Ifa$ $$Ifa$#$>HINd{ƊΊъҊيڊ܊݊ފߊƳƧƧƳ}}iYhU4hOJQJ\nHtH'hU4hCJKHPJaJnHo(tH&hU4hCJPJ\aJnHo(tH*hU4hCJPJQJ\aJnHo(tHhU4hOJQJ\$hU4hCJKHPJaJnHtH'hU4hCJKHPJaJnHo(tHhU4hQJ\hU4hB*CJo(phhU4hCJ\aJ6>HIdkmt{^U $$Ifa$kd"T$$Iflֈh  ^"9U{!64 la $$Ifa$ g^UUUUU $$Ifa$ $$Ifa$kdT$$Iflֈh  ^"9U{!64 laƊΊҊڊ܊ފg^UUUUG$$4$Ifa$gd $$Ifa$ $$Ifa$kdU$$Iflֈh  ^"9U{!64 laފߊUVWg[[[[[L$da$gd2 $da$kdYV$$Iflֈh  ^"9U{!64 laߊ':;S[lmwҋ؋ UVWXόЌьĴĪĪ܅}s^)hU4h5CJPJ\aJnHo(tHhU4h5o(hU4h5+hU4hCJOJPJQJaJnHo(tHhU4h2CJPJnHtHhU4h2CJo(hU4h2CJPJnHo(tHhU4h2CJhU4hCJPJnHtHhU4hCJo(hU4hCJhU4hCJPJnHo(tH!WXЌь ݍލfg&'cd9:/ $7$8$H$a$ ^`$da$ ܍ލZ[bcdeg;<hj%(!#8AbdRǽǽǽǭǽǭǽǽǭǭǽǽǽǽǽǭǽǽǭǽǽǭǽhU4h}CJPJnHo(tHhU4h@uCJPJnHo(tHhU4hCJPJnHo(tHhU4hCJo(hU4hCJ)hU4h5CJPJ\aJnHo(tHhU4h5CJaJo(hU4h5CJaJ7ӓ%&8:;.07<EF•ɕΕוؕ89dhx}ɖʖ˖ֽֽֽֽֽֽ3hU4hCJKHOJ PJQJ ^J aJnHo(tHhU4hAoCJPJnHo(tHhU4h)5CJPJnHo(tHhU4hCJhU4hHpSCJPJnHo(tHhU4hCJPJnHo(tHhU4hCJPJnHtHhU4hCJo(2/0•ʖ˖֖+Uy×З $$1$Ifa$7$8$H$$da$˖ad×Зї ,-.[\lyzȘɘϘܘݘޘߘ ŸŸŸhU4he CJKH hU4he CJPJaJnHtHhU4he CJKHPJaJhU4he CJaJhU4he CJPJaJhU4he CJKHaJhU4hCJKH'hU4h5CJKHPJaJnHtHhU4h5CJKHaJ0Зїؗ)!!$1$IfkdW$$Ifl %;IFC!%F1C*ppp$$$$44 la.R[ $$Ifa$ $$Ifa$gd_[\cl)!!$1$Ifkd1X$$IflY %;IFC!%F1C*ppp$$$$44 lalzȘ $$Ifa$ $$Ifa$gd_ȘɘϘ) $$1$Ifa$kdZY$$IflY %;IFC!%F1C*ppp$$$$44 laϘݘߘ $$Ifa$ $$Ifa$gd_ Lgi "#Z[\BDқӛԛ՛؛ۛܛޛߛ 25ɜʜ˜̜͜Μ-ƼhU4hCJPJnHo(tHhU4hvhCJPJnHo(tHhU4h@uCJPJnHo(tHhU4hCJhU4hCJo($hU4hCJKHPJaJnHtHhU4he CJKH hU4he CJPJaJnHtHhU4he CJaJ/KL"<6...$da$7$8$H$kdZ$$IflYִ%;IFC!%wC*ppp    44 la"#ߛ͜Μ-.=Pas $If^7$8$H$$da$-.<=OP`ars `anop±mZmI hU4hCJPJaJnHtH$hU4he CJPJ^JaJnHtH'hU4he CJPJ^JaJnHo(tH#hU4hCJPJaJnHo(tHhU4hCJaJo(#hU4he CJPJaJnHo(tH hU4hCJOJQJnHtH hU4h5B*CJaJph#hU4h5B*CJaJo(ph3hU4hCJKHOJ PJQJ ^J aJnHo(tHڝ ouooooo$Ifkd[$$Iflr !hn /"644 laopqȞɞߟ[uogogogogog$da$7$8$H$kd#\$$Iflr !hn /"644 la pqǞȞɞޞ:>@Aߟ÷yymy]My]yhU4h-8CJPJnHo(tHhU4hCJPJnHo(tHhU4h5CJ\hU4hCJo(hU4hCJ9hU4h5CJKHOJPJQJ\^JaJnHo(tHhU4h5CJaJo(hU4h5CJaJ3hU4hCJKHOJ PJQJ ^J aJnHo(tHhU4h5o(hU4h5hU4hKHPJnHo(tHߟ '+5Z\`aij<=>`aˮ{{hU4h-8CJPJnHo(tHhU4hCJPJnHo(tHhU4hCJo(hU4hCJ9hU4h5CJKHOJPJQJ\^JaJnHo(tHhU4h5CJaJo(hU4h5CJaJ3hU4hCJKHOJ PJQJ ^J aJnHo(tH*[\abmݨި $$1$Ifa$$7$8$H$]a$ ^` $da$gdo}_7$8$H$$da$abߢ =>rt٤ڤnˮqˮj\j\jhU4hPJnHo(tH hU4h3hU4hCJKHOJ PJQJ ^J aJnHo(tHhU4h-8CJPJnHo(tHhU4hCJo(hU4hCJ9hU4h5CJKHOJPJQJ\^JaJnHo(tHhU4h5CJaJo(hU4h5CJaJ3hU4hCJKHOJ PJQJ ^J aJnHo(tH!no˥DFx~KL`almӨƾy^TDhU4hCJPJnHo(tHhU4hCJo(4hU4h5;@KHOJPJQJ\nHo(tH&hU4h5CJPJaJnHo(tHhU4h5CJaJo(hU4h5CJaJ,hU4h5;CJPJ\aJnHo(tHhU4h5hU4h5o(hU4ho}_o(hU4ho}_CJo(hU4hPJnHo(tH hU4hhU4ho(Өܨݨި ˹˟mYK7$$hU4hCJKHPJaJnHtH'hU4h| CJKHPJaJnHo(tHhU4hCJKHaJo('hU4hCJKHPJaJnHo(tH/hU4h5CJKHOJPJQJaJnHtH2hU4h| 5CJKHOJPJQJaJnHo(tH2hU4h5CJKHOJPJQJaJnHo(tH#hU4h5CJKHOJQJaJ&hU4h5CJKHOJQJaJo(hU4hPJnHo(tHhU4hCJo(hU4hCJ <Vt $$1$Ifa$$1$Ifekd\$$IflF"&J &&J%6    44 la5 :<TVrtv(*d ˷~qb~qbN;$hU4h| CJKHPJaJnHtH'hU4h| CJKHPJaJnHo(tHhU4h| CJKHOJQJhU4h| CJKHaJhU4h| 5CJKHaJ/hU4h| CJKHOJPJQJaJnHo(tH$hU4hCJKHPJaJnHtH'hU4hCJKHPJaJnHo(tH#hU4h5CJKHOJQJaJ&hU4h5CJKHOJQJaJo(hU4hCJKHOJQJtvʪ (sk]]]]$$1$Ifa$gd| $1$IfkdH]$$Iflr>"&J &&&&%644 la5(*dƫsaSSSS$$1$Ifa$gd| L$1$IfWD^L`kd]$$Iflr>"&J ''''%644 la5 +<Ksk]]]]$$1$Ifa$gd| $1$Ifkdv^$$Iflr>"&J ''''%644 la5 +KLfg¬ìݬ-IJjkۭ"&'UVZ^_{|45;HQUYZmnhU4h| CJKHaJo($hU4h| CJKHPJaJnHtH'hU4h| CJKHPJaJnHo(tHhU4h| CJKHOJQJhU4h| CJKHaJhU4h| 5CJKHaJ>KLgxsk]]]]$$1$Ifa$gd| $1$Ifkd_$$Iflr>"&J ''''%644 la5ìЬݬsk]]]]$$1$Ifa$gd| $1$Ifkd_$$Iflr>"&J ''''%644 la5-;Isk]]]]$$1$Ifa$gd| $1$IfkdD`$$Iflr>"&J ''''%644 la5IJbkysk]OOOO$$1$Ifa$gd|  $1$IfWD` $1$Ifkd`$$Iflr>"&J ''''%644 la5ۭͭsaSSSS$$1$Ifa$gd|  $1$IfWDp^ `kdxa$$Iflr>"&J ''''%644 la5 "$&sk]]]]$$1$Ifa$gd| $1$Ifkdb$$Iflr>"&J ''''%644 la5&'VXZ\^saSSSS$$1$Ifa$gd|  $1$IfWDp^ `kdb$$Iflr>"&J ''''%644 la5^_|sk]]]]$$1$Ifa$gd| $1$IfkdFc$$Iflr>"&J ''''%644 la5'4saSSSS$$1$Ifa$gd|  $1$IfWDp^ `kdc$$Iflr>"&J ''''%644 la545QSUWYsm____$$1$Ifa$gd| $Ifkdzd$$Iflr>"J ''''%644 la5YZn|sk]]]]$$1$Ifa$gd| $1$Ifkde$$Iflr>"&J ''''%644 la5ïίٯsaSSSS$$1$Ifa$gd| D$1$IfWD^`Dkde$$Iflr>"&J ''''%644 la5¯ïٯ)CDMN|}ðİ4OPhi &'@AP_`uvxz{ͲƸƸَƸƸƸƸَƸƸƸƸhU4h| CJKHaJo(hU4h| CJKHOJQJhU4h| CJKHaJhU4h| 5CJKHaJ$hU4h| CJKHPJaJnHtH'hU4h| CJKHPJaJnHo(tH$hU4h| CJKHOJQJnHtH8)6CsaSSSS$$1$Ifa$gd|  $1$IfWDp^ `kdHf$$Iflr>"&J ''''%644 la5CD}saSSSS$$1$Ifa$gd|  $1$IfWD^` kdf$$Iflr>"&J ''''%644 la5İҰsk]]]]$$1$Ifa$gd| $1$Ifkd|g$$Iflr>"&J ''''%644 la5'4BOsk]]]]$$1$Ifa$gd| $1$Ifkdh$$Iflr>"&J ''''%644 la5OPiwsk]]]]$$1$Ifa$gd| $1$Ifkdh$$Iflr>"&J ''''%644 la5 &saSSSS$$1$Ifa$gd| $1$IfWD ^`kdJi$$Iflr>"&J ''''%644 la5&'ANP]_sk]]]]$$1$Ifa$gd| $1$Ifkdi$$Iflr>"&J ''''%644 la5_`vwxyzsk]]]]$$1$Ifa$gd| $1$Ifkd~j$$Iflr>"&J ''''%644 la5z{saSSSS$$1$Ifa$gd|  $1$IfWD^` kdk$$Iflr>"&J ''''%644 la5βӲزݲsaSSSS$$1$Ifa$gd|  $1$IfWD^` kdk$$Iflr>"&J ''''%644 la5Ͳβز>?]y./uմҿҿҿҿҿ}nWD$hU4hCJfHq &-jhU4hCJUfHq &hU4hCJaJnHtHhU4h5CJaJ'hU4h56PJ\]nHo(tHhU4hPJnHo(tH'hU4h| CJKHPJaJnHo(tH$hU4h| CJKHOJQJnHtHhU4h| CJKHaJhU4h| 5CJKHaJ$hU4h| CJKHPJaJnHtH.>saSSSS$$1$Ifa$gd|  $1$IfWD^` kdLl$$Iflr>"&J ''''%644 la5>?]kysaSSSS$$1$Ifa$gd|  $1$IfWD^` kdl$$Iflr>"&J ''''%644 la5 .saSSSS$$1$Ifa$gd|  $1$IfWD^` kdm$$Iflr>"&J ''''%644 la5./usaSSSS$$1$Ifa$gd|  $1$IfWD^` kdn$$Iflr>"&J ''''%644 la5;<sqg_q___q_$da$ T^kdn$$Iflr>"&J ''''%644 la5 մִٴ %9;<=stw>?@Šui[OhU4hq5CJo(hU4h5CJaJo(hU4h5CJo(hU4hCJaJ&hU4h5CJPJaJnHo(tHhU4h5CJaJ#hU4hCJPJaJnHo(tH$hU4hCJfHq &hU4hCJPJnHo(tHhU4hCJo(hU4hCJ-jhU4hCJUfHq &?@AG`aR]kdNo$$IfFrp#n0 .$    4 a%$!d$4$Ifa$gd7v%$!d$Ifa$gd7vd$If^`gd7vdgdq$da$@ABFGWX_`aefghlmnopάΘse[QsQQQeshU4hqCJo(hU4hq>*CJhU4hqCJnH o(tH hU4hqCJPJnHo(tHhU4hqCJhU4hq>*CJaJ&hU4hq>*CJOJQJnHo(tH'hU4hqCJOJPJQJnHo(tHhU4hq>*CJOJQJ'hU4hqCJOJPJQJnHo(tH$hU4hqCJOJPJQJnHtHhU4hqCJaJabchmnopSpkdo$$If\rp#n.$4 a$d$&dIfPa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpxk\$d$Ifa$gd7vZd$If^Z`gd7vpkd^p$$If\rp#n.$4 a$d$Ifa$gd7vzk\\$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkdp$$If\rp#n.$4 azk\\$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkdvq$$If\rp#n.$4 aͶζ϶ڶ $%+,8:@HI_ahopǷзѷҷطٷӞ%hU4hqhQCJPJnHo(tH#hU4hqCJPJaJnHo(tHhU4hqCJPJnHo(tHhU4hqCJnH o(tH hU4hqCJhU4hqCJaJhU4hqCJo(9ζ϶۶zkSS$d$&dIfPa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkdr$$If\rp#n.$4 azk\\$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkdr$$If\rp#n.$4 a zk\\$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkds$$If\rp#n.$4 a %+zk\K$d$4$Ifa$gd7v$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkds$$If\rp#n.$4 a+,9:AHzk\\$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkd2t$$If\rp#n.$4 aHI`aiozk\K$d$4$Ifa$gd7v$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkdt$$If\rp#n.$4 aopzk\\$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkdJu$$If\rp#n.$4 aȷѷzk\\$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkdu$$If\rp#n.$4 aѷҷzk\\$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkdbv$$If\rp#n.$4 a!zk\\$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkdv$$If\rp#n.$4 a  !"19ABCEFGHYZ\bijk}~ŸƸո )*'hU4hqCJOJPJQJnHo(tH *hU4hqCJhU4hqCJaJhU4hqCJPJnHo(tHhU4hqCJnH o(tH hU4hqCJo(hU4hqCJhU4hqh,*NCJ*CJaJ&hU4h,>*CJOJQJnHo(tH'hU4h,CJOJPJQJnHo(tH'hU4h,CJOJPJQJnHo(tHhU4h,>*CJOJQJhU4h,CJaJhU4h,5CJo(3hU4h5B*CJOJPJQJnHo(phtH'hU4h5B*CJOJQJo(ph$hU4hB*PJnHo(phtH׹عyeV>>$d$&dIfPa$gd{/$d$Ifa$gd{/Zd$If^Z`gd{/]kd$$IfFrp#n0 .$    4 a%$!d$Ifa$gd{/%$!d$Ifa$gd{/ zk\\$d$Ifa$gd{/$d$Ifa$gd{/Zd$If^Z`gd{/pkd6$$If\rp#n.$4 a ,zk\\$d$Ifa$gd{/$d$Ifa$gd{/Zd$If^Z`gd{/pkd€$$If\rp#n.$4 a!*,-12AJLRYZ[_`tĺǺкѺ [\^aghimn#hU4h,CJPJaJnHo(tHhU4h,h[CJaJhU4h,CJaJnH o(tH hU4h,CJaJo(hU4h,CJnH o(tH hU4h,CJPJnHo(tHhU4h,CJo(hU4h,CJhU4h,CJaJ5,-./01zk\\$d$Ifa$gd{/$d$Ifa$gd{/Zd$If^Z`gd{/pkdN$$If\rp#n.$4 a12KLSZxiQQ$d$&dIfPa$gd{/$d$Ifa$gd{/Xd$IfWD^X`gd{/pkdځ$$If\rp#n.$4 aZ[\]^_zk\\$d$Ifa$gd{/$d$Ifa$gd{/Zd$If^Z`gd{/pkdf$$If\rp#n.$4 a_`zk\\$d$Ifa$gd{/$d$Ifa$gd{/Zd$If^Z`gd{/pkd$$If\rp#n.$4 aĺȺкvj[[$d$Ifa$gd{/ d$Ifgd{/sd$IfVDvWD^`sgd{/pkd~$$If\rp#n.$4 aкѺ vgXX$d$Ifa$gd{/$d$Ifa$gd{/ud$IfVDvWD^`ugd{/pkd $$If\rp#n.$4 a]^bhv];;!$d$&dIfPWD^`a$gd{/$d$IfWD^`a$gd{/sd$IfVDvWD^`sgd{/pkd$$If\rp#n.$4 ahijklmzk\\$d$Ifa$gd{/$d$Ifa$gd{/Zd$If^Z`gd{/pkd"$$If\rp#n.$4 amnxiQQ$d$&dIfPa$gd{/$d$Ifa$gd{/d$IfWD^`gd{/pkd$$If\rp#n.$4 azk\\$d$Ifa$gd{/$d$Ifa$gd{/Zd$If^Z`gd{/pkd:$$If\rp#n.$4 azkSS$d$&dIfPa$gd{/$d$Ifa$gd{/Zd$If^Z`gd{/pkdƆ$$If\rp#n.$4 a.23AHJPWXYhirstyʺدددʺإʺدʺ؇د|hU4hB*ph *hU4h,CJ'hU4h,CJOJPJQJnHo(tHhU4h,CJo(hU4h,CJaJhU4h,CJPJnHo(tHhU4h,CJnH o(tH hU4h,CJ#hU4h,CJPJaJnHo(tHhU4h,CJaJo(*zk\\$d$Ifa$gd{/$d$Ifa$gd{/Zd$If^Z`gd{/pkdR$$If\rp#n.$4 a/012zk\\$d$Ifa$gd{/$d$Ifa$gd{/Zd$If^Z`gd{/pkdއ$$If\rp#n.$4 a23IJQX|m^^$d$Ifa$gd{/$d$Ifa$gd{/d$IfVDG^gd{/pkdj$$If\rp#n.$4 aXYstz|mUU$d$&dIfPa$gd{/$d$Ifa$gd{/d$IfVDG^gd{/pkd$$If\rp#n.$4 a|m^^$d$Ifa$gd{/$d$Ifa$gd{/d$IfVDG^gd{/pkd$$If\rp#n.$4 axiQQ$d$&dIfPa$gd{/$d$Ifa$gd{/Zd$If^Z`gd{/rkd$$If \rp#n.$4 azk\\$d$Ifa$gd{/$d$Ifa$gd{/Zd$If^Z`gd{/pkd$$If\rp#n.$4 aռּ׼ݼg\\SG $$Ifa$gd7v $Ifgd7v $da$gdq&9TPL HD@<+{d<^pkd*$$If\rp#n.$4 aԼռּ׼ؼܼݼxbxbxPAhU4hqCJOJQJaJ#hU4hq>*CJPJaJnHtH+hU4hqCJOJPJQJaJnHo(tH+hU4hqCJOJPJQJaJnHo(tH(hU4hqCJOJPJQJaJnHtHhU4hqCJo(hU4hqCJhU4hqCJaJhU4hqPJnHo(tHhU4hq5PJnHo(tHhU4h5o(,hU4hB*CJPJaJnHo(phtHݼPG; $$Ifa$gd7v $Ifgd7vpkd$$If\rY#F$4 a"%$!xd0$&dIfPUD2]xa$gdq%$!d8$&dIfPa$gd7v'tk_ $$Ifa$gd7v $Ifgd7vpkdH$$If\rY#F$4 a%$!xd0$IfUD2]xa$gdq&'*,-?ACWXYZ[\{|ϺϺϬϚoϚo^Ϛo^Ϛ hU4hqCJPJaJnHtH(hU4hqCJOJPJQJaJnHtH+hU4hqCJOJPJQJaJnH o(tH #hU4hqCJPJaJnHo(tHhU4hq5CJ\aJ(hU4hqCJOJPJQJaJnHtHhU4hqCJaJhU4hqCJOJQJaJ+hU4hq>*CJOJPJQJaJnHtH$'()*+,yZZ%$!xd0$IfUD2]xa$gdqob& $$Ifa$gd7v $Ifgd7vpkdԌ$$If\rY#F$4 a,-@ABCy__%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkd`$$If\rY#F$4 aCDWXZ\sYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkd$$If\rY#F$4 a\]{|sYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkdx$$If\rY#F$4 asYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkd$$If\rY#F$4 asYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkd$$If\rY#F$4 a (+6<=CDEcdelmt齬~f齬[~[F齬[[F(hU4hqCJOJPJQJaJnHtHhU4hqCJaJ.hU4hqhCJOJPJQJaJnHtHhU4hqCJaJo(hU4hqCJaJnH o(tH #hU4hqCJPJaJnHo(tH hU4hqCJPJaJnHtH+hU4hq>*CJOJPJQJaJnHtH+hU4hqCJOJPJQJaJnHo(tH+hU4hqCJOJPJQJaJnH o(tH  sYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkd$$If\rY#F$4 a56=DsYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkd$$If\rY#F$4 aDEdemusYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkd4$$If\rY#F$4 atuvɾʾ׾ھ۾ܾ߾  !()*FGͷؒͷ͢ͷ͢v͢ͷd#hU4h%/ CJPJaJnHo(tHhU4hq5CJaJhU4hqCJaJnH o(tH hU4h,CJaJnH o(tH (hU4hqCJOJPJQJaJnHtH+hU4hqCJOJPJQJaJnH o(tH hU4hqCJaJ hU4hqCJPJaJnHtH+hU4hq>*CJOJPJQJaJnHtH$uvsYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkd$$If\rY#F$4 aɾʾѾ׾yWW"%$!xd0$&dIfPUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkdL$$If\rY#F$4 a׾ؾپھ۾ܾy__%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkdؒ$$If\rY#F$4 aܾݾ޾߾yWW"%$!xd0$&dIfPUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkdd$$If\rY#F$4 ay__%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkd$$If\rY#F$4 a y__%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkd|$$If\rY#F$4 a !)sYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkd$$If\rY#F$4 a)*FHPXsYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkd$$If\rY#F$4 aGHOPWXYۿܿݿ޿׬z׬j׬jQאz׬1hU4hqhBCJOJPJQJaJnH o(tH hU4hqCJaJnH o(tH +hU4hqCJOJPJQJaJnHo(tHhU4hqCJaJ hU4hqCJPJaJnHtH+hU4hq>*CJOJPJQJaJnHtH(hU4hqCJOJPJQJaJnHtH+hU4hqCJOJPJQJaJnH o(tH #hU4hqCJPJaJnHo(tHXYsYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkd $$If\rY#F$4 asYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkd$$If\rY#F$4 aۿܿ޿sYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkd8$$If\rY#F$4 asYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkdė$$If\rY#F$4 a#sYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkdP$$If\rY#F$4 a"#$;<CDKLMOPQT]^ghiӽӧӽӧӁӧhӧӽӧ1hU4hqhCJOJPJQJaJnHo(tH(hU4hqCJOJPJQJaJnHtH hU4hqCJPJaJnHtH+hU4hq>*CJOJPJQJaJnHtH+hU4hqCJOJPJQJaJnHo(tH+hU4hqCJOJPJQJaJnH o(tH hU4hqCJaJo(hU4hqCJaJ(#$;<DLsQQ"%$!xd0$&dIfPUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkdܘ$$If\rY#F$4 aLMNOPQy__%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkdh$$If\rY#F$4 aQRST^hy__%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkd$$If\rY#F$4 ahisQQ"%$!xd0$&dIfPUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkd$$If\rY#F$4 ay__%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkd $$If\rY#F$4 ayWW"%$!xd0$&dIfPUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkd$$If\rY#F$4 ay__%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkd$$$If\rY#F$4 a#ҽޓkUkD4hU4hqCJaJnH o(tH hU4hqCJPJaJnHtH+hU4hqCJOJPJQJaJnHo(tH+hU4hqCJOJPJQJaJnH o(tH #hU4hqCJPJaJnHo(tH#hU4h%/ CJPJaJnHo(tH.hU4hq5>*CJOJPJQJaJnHtH(hU4hqCJOJPJQJaJnHtHhU4hq5CJaJhU4hqCJaJ+hU4hq>*CJOJPJQJaJnHtHy__%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkd$$If\rY#F$4 asYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkd<$$If\rY#F$4 a#$*0sYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkdȝ$$If\rY#F$4 a#$)*01LMNOPQR_dejklvxݳݒ|ݒ|ݒdݨݨݨ.hU4hq>*CJOJPJQJaJnHo(tH+hU4hq>*CJOJPJQJaJnHtH+hU4hqCJOJPJQJaJnHo(tHhU4hqCJaJ hU4hqCJPJaJnHtH1hU4hqhBCJOJPJQJaJnH o(tH +hU4hqCJOJPJQJaJnH o(tH hU4hqCJaJo(%01LMOQsYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkdT$$If\rY#F$4 aQR^_eksYY%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkd$$If\rY#F$4 aklwxsQQ"%$!xd0$&dIfPUD2]xa$gdq $$Ifa$gd7v$IfWDd`gd7vpkdl$$If\rY#F$4 athNN%$!xd0$IfUD2]xa$gdq $$Ifa$gd7va$IfVDnWDc^a`gdqoB=pkd$$If\rY#F$4 athNN%$!xd0$IfUD2]xa$gdq $$Ifa$gd7va$IfVDnWDc^a`gdqoB=pkd$$If\rY#F$4 aymKKKK"%$!xd0$&dIfPUD2]xa$gdq $$Ifa$gd7va$IfVDnWDc^a`gdqpkd$$If\rY#F$4 ay__%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkd$$If\rY#F$4 a $%,-.0123YZcdmnopqʴգʍգʴգʁʴգujhU4hu|$CJaJhU4hu|$5CJaJhU4hq5CJaJ+hU4hqCJOJPJQJaJnHo(tH hU4hqCJPJaJnHtH+hU4hqCJOJPJQJaJnH o(tH hU4hqCJaJ+hU4hq>*CJOJPJQJaJnHtH(hU4hqCJOJPJQJaJnHtH yWW"%$!xd0$&dIfPUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkd($$If\rY#F$4 ay__%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkd$$If\rY#F$4 a %-yWW"%$!xd0$&dIfPUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkd@$$If\rY#F$4 a-./012y__%$!xd0$IfUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkḍ$$If\rY#F$4 a23YZdnyWW"%$!xd0$&dIfPUD2]xa$gdq $$Ifa$gd7v $Ifgd7vpkdX$$If\rY#F$4 anopqrsy__%$!xd0$IfUD2]xa$gd{/ $$Ifa$gd7v $Ifgd7vpkd$$If\rY#F$4 aqst "+,567QRXY_`fst}ʿ~schU4hyCJaJnH o(tH hU4hyCJaJhU4hy5CJ\aJ#hU4h}CJPJaJnHo(tHhU4h}CJaJnH o(tH hU4h}CJPJaJnHtHhU4h}CJaJhU4h}5CJ\aJ hU4hu|$CJPJaJnHtH+hU4hu|$CJOJPJQJaJnH o(tH %stzk\\$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkdp$$If\rY#F$4 a|m^^$d$Ifa$gd7v$d$Ifa$gd7vd$IfWDd`gd7vpkd$$If\rY#F$4 avgXX$d$Ifa$gd7v$d$Ifa$gd7vnd$IfVDGWD2^`ngd}pkd$$If\rY#F$4 avgOO$d$&dIfPa$gd7v$d$Ifa$gd7vnd$IfVDGWD2^`ngd}pkd$$If\rY#F$4 azk\\$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkd$$If\rY#F$4 a!",6zk\\$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkd,$$If\rY#F$4 a67QRY`zkSS$d$&dIfPa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkd$$If\rY#F$4 a`abcdezk\\$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkdD$$If\rY#F$4 aefst~zkSS$d$&dIfPa$gd{/$d$Ifa$gd7vZd$If^Z`gd7vpkdЩ$$If\rY#F$4 a}~ ɻɛyyyyyymyyy^ɋyhU4h}CJOJQJaJhU4h}CJaJo(#hU4h}CJPJaJnHo(tHhU4h}CJaJnH o(tH hU4h}CJPJaJnHtHhU4h}5CJ\aJo(hU4h}5CJ\aJhU4h}CJaJhU4hyCJaJhU4hyCJaJnH o(tH hU4hyCJPJaJnHtH$zk\\$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkd\$$If\rY#F$4 azk\\$d$Ifa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkd$$If\rY#F$4 avgXX$d$Ifa$gd7v$d$Ifa$gd7vnd$IfVDGWD2^`ngd}pkdt$$If\rY#F$4 avgXX$d$Ifa$gd7v$d$Ifa$gd7vnd$IfVDGWD2^`ngd}pkd$$If\rY#F$4 avgOO$d$&dIfPa$gd7v$d$Ifa$gd7vnd$IfVDGWD2^`ngd}pkd$$If\rY#F$4 a|m^^$d$Ifa$gd7v$d$Ifa$gd7vd$IfVDG^gd}pkd$$If\rY#F$4 a%ufNN$d$&dIfPa$gd7v$d$Ifa$gd7v%!Zd$If^Z`gd7vpkd$$If\rY#F$4 a$%&'()-67@ABCIJLRST]^ҤlT8l87hU4h=;5@B*CJOJQJ\aJnH phtH /hU4h=;5@B*CJOJQJ\aJph>hU4h! 5@B*CJOJPJQJ\aJnHo(phtH/hU4h! 5@B*CJOJQJ\aJphhU4hqPJnHo(tH hU4h}CJPJaJnHtHhU4h}CJOJQJaJhU4h}CJaJ#hU4h}CJPJaJnHo(tHhU4h}CJaJnH o(tH %&'()*ufWW$d$Ifa$gd7v$d$Ifa$gd7v%!Zd$If^Z`gd7vpkd0$$If\rY#F$4 a*+,-7AzkSS$d$&dIfPa$gd7v$d$Ifa$gd7vZd$If^Z`gd7vpkd$$If\rY#F$4 aABC~qhYQ$da$$d^a$gdCicd^ d^`^gd=;gdqpkdH$$If\rY#F$4 a^_lmwxఙ||qfTCTf hU4hCicCJPJaJnHtH#hU4hCicCJPJaJnHo(tHhU4hCicCJaJhU4hCJaJhU4h5CJ\aJo(hU4h5CJ\aJ,hU4hB*CJPJaJnHo(phtH/hU4h=;5@B*CJOJQJ\aJph/hU4h! 5@B*CJOJQJ\aJph>hU4h! 5@B*CJOJPJQJ\aJnHo(phtH*77TZb()"#$mŵţ{o{]{o{o{o]o{o{]o{#hU4h CJPJaJnHo(tHhU4h CJaJo(hU4h CJaJhU4h5CJ\aJhU4h5CJ\aJo(#hU4hyCJPJaJnHo(tHhU4hCicCJaJnH o(tH hU4hCicCJPJaJnHtH#hU4hCicCJPJaJnHo(tHhU4hCicCJaJhU4hCicCJaJo("()#$U$c$7$8$H$IfWD^c`a$gd7v$$7$8$H$Ifa$gd7v$d^a$gd d & Fd1$ mnxy@BUVijŹwwwee# *hU4h CJPJ aJnHtH+hU4h CJOJ QJ ^J aJnH o(tH hU4h CJOJ QJ ^J aJ *hU4h CJPJ aJhU4h CJPJ aJ *hU4h CJaJ hU4h CJPJaJnHtHhU4h CJaJnH o(tH hU4h CJaJhU4h CJaJnH tH %UVj}'Ukd<$$If$0"0 t644 la$c$7$8$H$IfWD^c`a$gd7v$$7$8$H$Ifa$gd7vUkdԯ$$If0"0 t644 la}b$n$7$8$H$IfWD^n`a$gd7vUkd$$If0"0 t644 la$$7$8$H$IfWD^`a$gd7v$$7$8$H$Ifa$gd7v<is$$7$8$H$IfWD^`a$gd7v$R$7$8$H$IfWD^`Ra$gd7vUkd $$If0"0 t644 la&)*,;<ijsuvwy|}STghʹجʹʡr`Hr.hU4hX>CJH*OJ QJ ^J aJnH o(tH #hU4hX>CJOJ QJ ^J aJo(hU4hX>CJPJ aJ hU4hX>CJOJ QJ ^J aJ hU4hX>CJPJaJnHtHhU4h CJaJhU4h CJPJ aJ hU4h CJOJ QJ ^J aJ *hU4h CJPJ aJhU4h CJPJ aJo(hU4h CJPJ aJhU4h CJPJ aJij}}'Ukdܱ$$If0"0 t644 la$c$7$8$H$IfWD^c`a$gd7v$$7$8$H$Ifa$gd7vUkdt$$If0"0 t644 laSThTUkdD$$If0@p#0 t!644 la$c$7$8$H$IfWD^c`a$gd{/$$7$8$H$Ifa$gd{/ $da$gdX>$d^a$gd $d7$8$H$a$gd ,5@ACKL^_`a0123Aʧ|󑹑ʹnʑnʑnnʑn *hU4hX>CJPJ aJ(hU4hX>CJOJ QJ ^J aJnH tH +hU4hX>CJOJ QJ ^J aJnH o(tH #hU4hX>CJPJ aJnH o(tH hU4hX>CJPJ aJnHtH.hU4hX>CJH*OJ QJ ^J aJnH o(tH hU4hX>CJOJ QJ ^J aJhU4hX>CJPJ aJ+}'Ukd$$If0@p#0 t!644 la$d$IfWD^`$gd{/d$IfWD^`gd{/Ukd$$If0@p#0 t!644 laBCL`ajBUkd$$If0@p#0 t!644 laUkd|$$If0@p#0 t!644 la$$7$8$H$Ifa$gd{/j8Zkd$$If0@p#0 t!644 lagb=ZkdL$$If0@p#0 t!644 lagb=$$7$8$H$Ifa$gd{/23B8Zkd$$If0@p#0 t!644 lagb=Zkd0$$If0@p#0 t!644 lagb=$$7$8$H$Ifa$gd{/ABSTUVdeJKLܠܶĠzmzm[zm[m[zI#hU4h H*OJ QJ ^J nH tH #hU4h OJ QJ ^J nH o(tH hU4h OJ QJ ^J &hU4h H*OJ QJ ^J nH o(tH #hU4h CJPJaJnHo(tH+hU4hX>CJOJ QJ ^J aJnH o(tH  *hU4hX>CJPJ aJ.hU4hX>CJH*OJ QJ ^J aJnH o(tH hU4hX>CJOJ QJ ^J aJ#hU4hX>CJOJ QJ ^J aJo(BUVe8Zkd$$If0@p#0 t!644 lagb=Zkd$$If0@p#0 t!644 lagb=$$7$8$H$Ifa$gd{/K?uuuuffff$d^a$gd 7$8$H$VD^gd $d7$8$H$a$gd Zkd$$If0@p#0 t!644 lagb=$$7$8$H$Ifa$gd{/ 34kl=@%&~Z[GHhiWX#$#hU4h CJPJaJnHo(tHhU4h CJaJhU4h CJaJo(*hU4h H*OJ PJQJ ^J nHo(tHhU4h;MOJ QJ ^J hU4h OJ QJ ^J nH tH @?@VWno,VD]^gd ,BVD]^Bgd  & FH7$8$H$^`Hgd $d^a$ d^`^ $da$gd $d^a$gd %:VWZnode󿳦pf]fMppp< hU4h CJPJaJnHtHhU4h PJaJnHo(tHhU4h aJhU4h aJo(#hU4h CJPJaJnHo(tH#hU4h 5CJPJaJnHtH#hU4hCJPJaJnHo(tHhU4h5CJ\o(hU4h5CJ\,hU4hB*CJPJaJnHo(phtH#hU4he{CJPJaJnHo(tHhU4h CJaJhU4h CJaJo(LJLkd۷$$If0p#/ !4 a8Lkdj$$If0p#/ !4 a8$d$Ifa$gd7v d$Ifgd7vMNPehs vx⼬nZ&hU4h >*CJPJaJnHo(tH"hU4h >*CJaJnH o(tH #hU4h 5CJPJaJnHtHhU4h CJPJnHo(tHhU4h aJo(hU4h PJaJnHo(tHhU4h aJ hU4h CJPJaJnHtHhU4h CJ]aJhU4h CJaJ#hU4h CJPJaJnHo(tH LMNOPghYJ$d$Ifa$gd7vLkdø$$If0p#/ !4 a8 d$Ifgd7vLkdL$$Ifq0p#/ !4 a8EQkd$$If0p#/ !4 a8gc&$d$Ifa$gd7v d$Ifgd7vLkd@$$If0p#/ !4 a8 YJBdgd ,BVD]^Bgd Lkd$$If0p#/ !4 a8 d$Ifgd7vLkd8$$If0p#/ !4 a8vx+zzzzzzz$d$$&dIfPa$gd{/&d$$If^`&gd{/$\d$VDQ^\`a$gd5 $\#d$VDQ^\`#a$gd A7$8$H$VD^`Agd 7$8$H$VD^gd & F7$8$H$gd ,W_`xxfZLxhU4h5 h CJaJhU4h5 CJ]aJ#hU4h5 CJPJ]aJnHtHhU4h5 CJaJhU4h5 >*CJ hU4h5 CJPJaJnHtH#hU4h5 CJPJaJnHo(tHhU4h5 CJaJhU4h5 >*CJaJ&hU4h >*CJPJaJnHo(tH"hU4h >*CJaJnH o(tH #hU4h >*CJPJaJnHtH+HIJWXY_$d$$&dIfPa$gd{/_`a,&d$$If^`&gd{/kd,$$If֞ ^:!%nnnn0p#4 a8aiqy$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/,&d$$If^`&gd{/kd$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/,&d$$If^`&gd{/kd$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/,&d$$If^`&gd{/kd$$If֞ ^:!%nnnn0p#4 a8 !#$%+,.3\]ghiopxʷʷʷʷʷʷʬʷʬʁʬڠp hU4h5 CJPJaJnHtH&hU4h5 hewCJPJaJnHtHhU4h5 CJaJhU4h5 CJ]aJhU4h5 CJaJ%hU4h5 hewCJaJnH o(tH hU4h5 CJaJnH o(tH #hU4h5 CJPJ]aJnHtH&hU4h5 CJPJ]aJnHo(tH,$d$$Ifa$gd{/oԦ,d$$If^`gd{/kdؾ$$If֞ ^:!%nnnn0p#4 a8!#$d$$&dIfPa$gd{/oԦ$d$$&dIfPa$gd{/#$%,&d$$If^`&gd{/kdƿ$$If֞ ^:!%nnnn0p#4 a8%&'()*+$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/+,3,qd$$IfVDWD^`qgd{/kd$$If֞ ^:!%nnnn0p#4 a83;CKS]g$d$$&dIfPa$gd{/ghi,&d$$If^`&gd{/kd$$If֞ ^:!%nnnn0p#4 a8ijklmno$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/op,qd$$IfVDWD^`qgd{/kd$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gd{/$d$$Ifa$gd{/oԦ$d$$&dIfPa$gd{/,&d$$If^`&gd{/kd~$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/,&d$$If^`&gd{/kdl$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/, d$$Ifgd{/kdZ$$If֞ ^:!%nnnn0p#4 a8,.JRTfhzϾᎾn\nQhU4h5 CJaJ"hU4h^CJ]aJnH o(tH &hU4h^CJPJ]aJnHo(tHhU4h^CJ]aJhU4h5 CJ]aJhU4h5 CJaJnH o(tH &hU4h5 hewCJPJaJnHtH hU4h5 CJPJaJnHtH#hU4h5 CJPJ]aJnHtH&hU4h5 CJPJ]aJnHo(tHhU4h5 CJaJ$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/,&d$$If^`&gd{/kdH$$If֞ ^:!%nnnn0p#4 a8,$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/,.J,&d$$If^`&gd{/kd6$$If֞ ^:!%nnnn0p#4 a8JLNPRTf$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/fh,&d$$If^`&gd{/kd$$$If֞ ^:!%nnnn0p#4 a8$d$$&dIfPa$gd{/$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/,&d$$If^`&gd{/kd$$If֞ ^:!%nnnn0p#4 a8$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/$\rtvx|ﲢ|j|j^SA0A hU4hTCJPJaJnHtH#hU4hTCJPJaJnHo(tHhU4hTCJaJhU4hT>*CJaJ#hU4h >*CJPJaJnHtH&hU4h >*CJPJaJnHo(tH"hU4h >*CJaJnH o(tH hU4h5 CJaJnH o(tH &hU4h5 hewCJPJaJnHtH#hU4h5 CJPJ]aJnHtHhU4h5 CJ]aJhU4h5 CJaJ hU4h5 CJPJaJnHtH,&d$$If^`&gd{/kd$$If֞ ^:!%nnnn0p#4 a8$d$$&dIfPa$gd{/$d$$Ifa$gd{/,$\#d$VDQ^\`#a$gd kd$$If֞ ^:!%nnnn0p#4 a8tvxz$%&,$d$$&dIfPa$gd{/&d$$If^`&gd{/$\d$VDQ^\`a$gdTA7$8$H$VD^`Agd $,-^_fgnostuvwxҽҽォt_____)hU4hThewCJPJaJnHo(tH&hU4hTCJPJ]aJnHo(tH)hU4hTh CJPJaJnHo(tHhU4hTCJ]aJo(#hU4hTCJPJ]aJnHtHhU4hTCJaJhU4hT>*CJhU4hTCJaJ#hU4hTCJPJaJnHo(tH hU4hTCJPJaJnHtH%,-.6>FS?000$d$$Ifa$gd{/&d$$If^`&gd{/kd$$If֞ ^:!%nnnnp#4 a8FNV^_0kd$$If֞ ^:!%nnnnp#4 a8$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/_`abcdef$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/&d$$If^`&gd{/fgopqrS?000$d$$Ifa$gd{/&d$$If^`&gd{/kdT$$If֞ ^:!%nnnnp#4 a8rstuv0kd$$If֞ ^:!%nnnnp#4 a8$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/v$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/&d$$If^`&gd{/oԦS?''$d$$&dIfPa$gd{/d$$If^`gd{/kd$$If֞ ^:!%nnnnp#4 a8;kd$$If֞ ^:!%nnnnp#4 a8$d$$&dIfPa$gd{/()2345;<DKLRSYZefgmnopvwøæڕڕڕڕøæڕڕڕsڕøϦÁڕhU4hThewCJaJ&hU4hTCJPJ]aJnHo(tH hU4hTCJPJaJnHtH#hU4hTCJPJ]aJnHtHhU4hTCJaJhU4hTCJ]aJhU4hTCJaJ#hU4hTCJPJaJnHo(tH&hU4hThewCJPJaJnHtH-$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/&d$$If^`&gd{/S;#$d$$&dIfPa$gd{/qd$$IfVDWD^`qgd{/kd@$$If֞ ^:!%nnnnp#4 a8)34;kd$$If֞ ^:!%nnnnp#4 a8$d$$&dIfPa$gd{/456789:;$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/&d$$If^`&gd{/;<LSS;#$d$$&dIfPa$gd{/qd$$IfVDWD^`qgd{/kd$$If֞ ^:!%nnnnp#4 a8SZ`fgn$d$$Ifa$gd{/$d$$Ifa$gd{/oԦ$d$$&dIfPa$gd{/nopqrsS?000$d$$Ifa$gd{/&d$$If^`&gd{/kdq$$If֞ ^:!%nnnnp#4 a8stuvw0kd,$$If֞ ^:!%nnnnp#4 a8$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/w$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/&d$$If^`&gd{/S?000$d$$Ifa$gd{/&d$$If^`&gd{/kd$$If֞ ^:!%nnnnp#4 a8  ϾϾlZl"hU4h^CJ]aJnH o(tH &hU4h^CJPJ]aJnHo(tHhU4h^CJ]aJhU4hTCJ]aJ#hU4hTCJPJaJnHo(tH&hU4hThewCJPJaJnHtH hU4hTCJPJaJnHtH#hU4hTCJPJ]aJnHtH&hU4hTCJPJ]aJnHo(tHhU4hTCJaJ0kd$$If֞ ^:!%nnnnp#4 a8$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/&d$$If^`&gd{/S?000$d$$Ifa$gd{/&d$$If^`&gd{/kd]$$If֞ ^:!%nnnnp#4 a80kd$$If֞ ^:!%nnnnp#4 a8$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/ !'$d$$&dIfPa$gd{/$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/&d$$If^`&gd{/ !&'()-/07CGHOPQWXY,RZ[afoĸĸχĸsbPbPbPb#hU4h CJPJaJnHo(tH hU4h CJPJaJnHtH&hU4h >*CJPJaJnHo(tH&hU4hThewCJPJaJnHtH#hU4hTCJPJ]aJnHtHhU4hTCJaJhU4hTCJ]aJhU4hTCJaJ hU4hTCJPJaJnHtH#hU4hTCJPJaJnHo(tHhU4hThewCJaJ'()*+,S?000$d$$Ifa$gd{/&d$$If^`&gd{/kd$$If֞ ^:!%nnnnp#4 a8,-./00kd$$If֞ ^:!%nnnnp#4 a8$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/0CDEFGHO$d$$&dIfPa$gd{/$d$$Ifa$gd{/&d$$If^`&gd{/OPQRSTS?000$d$$Ifa$gd{/&d$$If^`&gd{/kdI$$If֞ ^:!%nnnnp#4 a8TUVWX0kd$$If֞ ^:!%nnnnp#4 a8$d$$Ifa$gd{/oԦ$d$$Ifa$gd{/XY NP{lggd $d$`a$gd $\d$VDQ^\`a$gd $d$WD`a$gd $d$a$gd  & FS7$8$H$^Sgd dgd A7$8$H$VD^`Agd $-7$8$H$VD^-a$gd $\#d$VDQ^\`#a$gd oux|NPVdfnܻp`N*CJaJnH o(tH #hU4h >*CJPJaJnHtHhU4h CJaJnH o(tH &hU4h 5CJPJaJnHo(tH#hU4h 5CJPJaJnHtH%hU4h 5CJPJ\nHo(tH#hU4h CJPJaJnHo(tH hU4h CJPJaJnHtHhU4h^CJaJnH o(tH hU4h^CJPJaJnHtH#hU4h^CJPJaJnHo(tHnpv4DFH "*,.FȻvvvbRvRvbhU4h CJaJnH o(tH &hU4h CJPJ]aJnHo(tHhU4h CJaJhU4h CJaJ hU4h CJPJaJnHtH#hU4h CJPJaJnHo(tHhU4h CJ]aJhU4h PJnHtH#hU4h >*CJPJaJnHtH"hU4h >*CJaJnH o(tH &hU4h >*CJPJaJnHo(tH 68D$d$$&dIfPa$gd7v&d$$If^`&gd7vDFHXhxfRCCCCC$d$$Ifa$gd7v&d$$If^`&gd7vkd$$Ifֈq mG$ nt"4 a8fRCCCCC$d$$Ifa$gd7v&d$$If^`&gd7vkd$$Ifֈq mG$ nt"4 a8 fRCCCCC$d$$Ifa$gd7v&d$$If^`&gd7vkdA$$Ifֈq mG$ nt"4 a8 "$&(*,fRCCCCC$d$$Ifa$gd7v&d$$If^`&gd7vkd$$Ifֈq mG$ nt"4 a8,.hjlnpfRCCCC$d$$Ifa$gd7v&d$$If^`&gd7vkd$$Ifֈq mG$ nt"4 a8FXfhlpȽȆzjXL:"hU4h >*CJaJnH o(tH hU4h >*CJaJ#hU4h >*CJPJaJnHtHhU4h CJaJnH o(tH hU4h CJaJo(hU4h CJaJnH o(tH hU4h CJ]aJhU4h CJaJhU4h CJaJnH o(tH hU4h CJaJ hU4h CJPJaJnHtH&hU4h CJPJ]aJnHo(tH#hU4h CJPJ]aJnHtHpN:+$d$$Ifa$gd7v&d$$If^`&gd7vkd$$Ifֈq mG$ nt"4 a8$d$$&dIfPa$gd7vWC&d$$If^`&gd7vkdE$$Ifֈq mG$ nt"4 a8$d$$Ifa$gd7v?kd$$Ifhֈq mG$ nt"4 a8$d$$&dIfPa$gd7v$d$$Ifa$gd7v@B\$d$$&dIfPa$gd7v&d$$If^`&gd7vgd $d$`a$gd $\d$VDQ^\`a$gd >@BDZ\$&(24PRdȻvvvdThU4h CJaJnH o(tH #hU4h CJPJ]aJnHtHhU4h CJaJhU4h CJaJ hU4h CJPJaJnHtH#hU4h CJPJaJnHo(tHhU4h CJ]aJhU4h PJnHtH#hU4h >*CJPJaJnHtH"hU4h >*CJaJnH o(tH &hU4h >*CJPJaJnHo(tH$fRCCCCC$d$$Ifa$gd7v&d$$If^`&gd7vkd$$Ifֈq mG$ nt"4 a8$&(*,.02fRCCCCC$d$$Ifa$gd7v&d$$If^`&gd7vkd$$Ifֈq mG$ nt"4 a824RfvfRCCCCC$d$$Ifa$gd7v&d$$If^`&gd7vkdI$$Ifֈq mG$ nt"4 a8df"%)2345ʿ֫ʿ֙vfR&hU4h >*CJPJaJnHo(tHhU4h CJ]aJnH tH "hU4h CJ]aJnH o(tH hU4h CJPJaJnHtH#hU4h CJPJ]aJnHtH&hU4h CJPJ]aJnHo(tHhU4h CJaJhU4h CJ]aJhU4h CJaJhU4h CJaJnH o(tH hU4h CJaJnH tH fRCCCCC$d$$Ifa$gd7v&d$$If^`&gd7vkd $$Ifֈq mG$ nt"4 a8fRCCCC$d$$Ifa$gd7v&d$$If^`&gd7vkd$$Ifֈq mG$ nt"4 a8 N:+$d$$Ifa$gd7v&d$$If^`&gd7vkd$$Ifֈq mG$ nt"4 a8$d$$&dIfPa$gd7v "WC&d$$If^`&gd7vkdM$$Ifֈq mG$ nt"4 a8$d$$Ifa$gd7v"&'()3$&d$$&dIfP^`&a$gd7v$&d$$If^`&a$gd7v345/fWHC6 d^`d$d$^a$gd $d$`a$gd kd$$Ifֈq mG$ nt"4 a85 3=@o}./0BJepqsݺyoydXhU4h CJaJo(hU4h CJaJhU4h CJ\"hU4h CJPJ\nHo(tHhU4h CJ\o(hU4hCJ\hU4h5CJ\o(hU4h5CJ\%hU4h5>*CJPJnHo(tHhU4h CJaJnH o(tH #hU4h CJPJaJnHo(tH hU4h CJPJaJnHtH!/0rstzdL$d$&dIfPa$gd7v#qd$IfWD^`qgd7vOkd$$If440B# T"4 a8f4$d$Ifa$gd7v d$Ifgd7v$d`a$gd $d^a$().456XYZ^_`l29BCJMO{ܨʨܸʛܨʨhU4h CJnH tH hU4h CJaJnH o(tH hU4h CJaJ hU4h #hU4h CJPJaJnHo(tHhU4h CJaJo(hU4h CJaJnH tH hU4h CJ=o``$d$Ifa$gd7v#qd$IfWD^`qgd7vbkdE$$If44FBY#T"    4 a8f4$d$&dIfPa$gd7vxx$d$Ifa$gd7v#qd$IfWD^`qgd7vbkd$$If44FBY#T"    4 a8f4xx$d$Ifa$gd7v#qd$IfWD^`qgd7vbkdc$$If44FBY#T"    4 a8f4xx$d$Ifa$gd7v#qd$IfWD^`qgd7vbkd$$If44FBY#T"    4 a8f4)/5xx$d$Ifa$gd7v#qd$IfWD^`qgd7vbkd$$If44FBY#T"    4 a8f456Y[_xx$d$Ifa$gd7v#qd$IfWD^`qgd7vbkd$$If44FBY#T"    4 a8f4_`xx$d$Ifa$gd7v#qd$IfWD^`qgd7vbkd$$If44FBY#T"    4 a8f4xx$d$Ifa$gd7v#qd$IfWD^`qgd7vbkd%$$If44FBY#T"    4 a8f4 sb$d$4$Ifa$gd7v$d$Ifa$gd7v#qd$IfWD^`qgd7vgkd$$If44FBY#T"    4 a8f4gc&2:Bxx$d$Ifa$gd7v#qd$IfWD^`qgd7vbkdG$$If44FBY#T"    4 a8f4BC|yy$d$&dIfPa$gd7v #d$Ifgd7vbkd$$If44FBY#T"    4 a8f4 )̿vjaRj@j@9Rv hU4h%O#hU4h%OCJPJaJnHo(tHhU4h%OCJaJnH tH hU4h%OCJhU4h%OCJaJo(hU4h%OCJaJ"hU4h%OCJPJ\nHo(tHhU4h%OCJ\o(hU4h%OCJ\hU4hCJ\hU4hCJ\o(hU4h5CJ\o(hU4h5CJ\"hU4hCJPJ\nHo(tHhU4h CJhU4h CJaJo( |jj^O$d$Ifa$gd7v d$Ifgd7vVdUD]V^gd%O $d^a$ d^`$da$bkd_$$If44FBY#T"    4 a8f4 $d$&dIfPa$gd7v#qd$IfWD^`qgd7vOkd$$If440B# T"4 a8f4!)xx$d$Ifa$gd7v#qd$IfWD^`qgd7vbkda$$If44FBY#T"    4 a8f4)*+7Dxx$d$Ifa$gd7v#qd$IfWD^`qgd7vbkd$$If44FBY#T"    4 a8f4)*+DEFHIQXbz}ߊ꥓~~ߊ~꥓~qdhU4h%O5CJ\o(hU4h%OCJnH tH hU4h%OCJaJo(hU4h%OCJ#hU4h%OCJPJaJnHo(tHhU4h%OCJaJnH o(tH hU4h%O5CJaJ#hU4h%OCJPJ]aJnHtHhU4h%OCJ]aJhU4h%OCJaJhU4h%OCJaJnH tH hU4h%O$DEFGHss$d$Ifa$gd7vo[c&#qd$IfWD^`qgd7vbkd$$If44FBY#T"    4 a8f4HIss$d$Ifa$gd7v#qd$IfWD^`qgd7vgkd$$If44FBY#T"    4 a8f4g[c&oo$d$&dIfPa$gd7v#qd$IfWD^`qgd7vbkd$$If44FBY#T"    4 a8f4xx$d$Ifa$gd7v#qd$IfWD^`qgd7vbkd9$$If44FBY#T"    4 a8f4jR$d$&dIfPa$gd7v$}d$&dIfPa$gd7v#qd$IfWD^`qgd7vbkd$$If44FBY#T"    4 a8f4zma $d^a$ d^`^$VdUD]V^a$gd%Odgd%ObkdQ$$If44FBY#T"    4 a8f4 5DJK^l,-KW48DVWŹphU4hCJPJnHo(tHhU4hCJo(hU4hCJhU4hCJo(hU4hCJ%hU4h5CJPJ\nHo(tHhU4h5CJ\hU4h5CJ\o(,hU4hB*CJPJaJnHo(phtHhU4h%OCJ\o(hU4h%OCJ\,W]dgjmprty2OSX\]jخ{nbO%hU4h5CJPJ\nHo(tHhU4h5CJ\hU4h5CJ\o(,hU4hB*CJPJaJnHo(phtH hU4hCJPJaJnHtHhU4hCJaJ#hU4hCJPJaJnHo(tHhU4hCJo(hU4hCJnH o(tH hU4hCJPJnHo(tHhU4hCJhU4hCJPJnHtHNO$d$Ifa$gd7v d$Ifgd7v$HdVDWD8^`Ha$gdd^ d^`^ d^gd$d^a$gd <@AMN ׽׫ͫ׫|jjc|c|c|| hU4h#hU4hCJPJaJnHo(tHhU4hCJaJnH tH hU4hCJhU4hCJaJo(hU4hCJaJ"hU4hCJPJ\nHo(tHhU4hCJ\nH o(tH hU4hCJ\hU4hCJ\o(hU4h5>*CJhU4hCJPJnHo(tH&$d$&dIfPa$gd7v#qd$IfWD^`qgd7vOkd$$If440B# T"4 a8f4xx$d$Ifa$gd7v#qd$IfWD^`qgd7vbkdS$$If44FBY#T"    4 a8f4xx$d$Ifa$gd7v#qd$IfWD^`qgd7vbkd$$If44FBY#T"    4 a8f4xx$d$Ifa$gd7v#qd$IfWD^`qgd7vbkdq$$If44FBY#T"    4 a8f4 xx$d$Ifa$gd7v#qd$IfWD^`qgd7vbkd$$If44FBY#T"    4 a8f4 oooooooo$d$&dIfPa$gd7v#qd$IfWD^`qgd7vbkd$$If44FBY#T"    4 a8f4 ѷᦒn[OB[B9hU4hCJhU4h5CJ\o(hU4h5CJ\%hU4h5CJPJ\nHo(tH,hU4hB*CJPJaJnHo(phtHhU4hCJnH tH 'hU4hCJPJQJaJnHo(tH hU4hCJPJaJnHtHhU4hCJaJhU4hCJaJnH tH hU4hCJaJnH o(tH hU4hCJaJo(#hU4hCJPJaJnHo(tH~rZZZ$d$&dIfPa$gd{/ d$Ifgd{/ d^gdT d^`^bkd$$If44FBY#T"    4 a8f4  krsz| T[̺쪙쪙xxe$hU4hTCJOJQJaJnHtHhU4hTCJOJQJaJ#hU4hTCJPJaJnHo(tH hU4hTCJPJaJnHtHhU4hTCJaJnH o(tH #hU4hT>*CJPJaJnHtH&hU4hT>*CJPJaJnHo(tHhU4hTCJaJo(hU4hTCJaJhU4hTCJ' !)1$d$Ifa$gd{/ d$Ifgd{/]kd$$IflF#&T"    4 la123?J#$d$Ifa$gd{/ d$Ifgd{/]kd$$IflF#&T"    4 laJKLMN#$d$Ifa$gd{/ d$Ifgd{/]kd$$IflF#&T"    4 laNOks{#$d$Ifa$gd{/ d$Ifgd{/bkd$$IflF#&T"    4 lagF{|uu#$d$&dIfPa$gd{/d$If^`gd{/]kda$$IflF#&T"    4 la#$d$Ifa$gd{/ d$Ifgd{/]kd$$IflF#&T"    4 laxx$d$&dIfPa$gd{/%!d$Ifgd{/]kd9$$IflF#&T"    4 la $$Ifa$gd{/%!$Ifgd{/]kd$$IflF#&T"    4 la  $$Ifa$gd{/%!$Ifgd{/]kd$$IflF#&T"    4 laT\duu#$d$&dIfPa$gd{/d$If^`gd{/]kd}$$IflF#&T"    4 la[\cefijpqwyz}UWXZaefhiswxyů|p|p^|p|p^UhU4hgCJ#hU4hgCJPJaJnHo(tHhU4hgCJaJo(hU4hgCJaJhU4hgCJ\hU4hgCJ\o("hU4hgCJPJ\nHo(tH+hU4hTCJOJPJQJaJnHo(tHhU4hTCJaJhU4hTCJOJQJaJhU4hTCJaJnH o(tH hU4hTCJPJaJnHtHdefgh $$Ifa$gd{/%!$Ifgd{/]kd$$IflF#&T"    4 lahijqx~~$$&dIfPa$gd{/%!$Ifgd{/]kdU$$IflF#&T"    4 laxyz{| $$Ifa$gd{/%!$Ifgd{/]kd$$IflF#&T"    4 la|}~~$$&dIfPa$gd{/%!$Ifgd{/]kd-$$IflF#&T"    4 laVWXafxqqq$d$&dIfPa$gd7v d$Ifgd7v d^gdg]kd$$IflF#&T"    4 laxyz||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd$$IfF#&U"    4 a8yz-12567GHIJMNOPQRSZ[bcdeqƸƬƸƬ֪ƸƬƘƸƬրhU4hgCJ\o( *hU4hgCJaJ" *hU4hgCJaJnH o(tH UhU4hgCJaJo( *hU4hgCJaJo(hU4hgCJaJnH o(tH hU4hgCJ hU4hghU4hgCJaJhU4hgCJaJnH tH 0||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd$$IfF#&U"    4 a8||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd $$IfF#&U"    4 a8||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd$$IfF#&U"    4 a8||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd$$IfF#&U"    4 a8.26||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd$$IfF#&U"    4 a8More than two years but less than three years146319Over three years-26377,164306,256The Groups revenue from export sales is on letter of credit or documents against payment. The credit period is agreed upon in the sales contract. Except for some particular customers where payment in advance is normally required, the Group allows an average credit period of 30 days to its local trade customers and 90 days for local hospital customers. 9. Trade and other payablesThe following is an aged analysis of accounts payable presented based on the invoice date at the end of the reporting period.30 June 201131 December 2010RMB000RMB000(unaudited)(audited)Within one year274,957311,497More than one year but less than two years2,6306,048More than two years but less than three years5033,630Over three years5,7745,738283,864326,913Other payables and accrued charges146,063177,001429,927503,91410. Related party transaction Significant related party transactions, which were carried out in the normal course of the Groups business are as follows:Six months ended 30 June20112010RMB000RMB000(unaudited) (unaudited)SXPGC - Payment of annual trademark license fee (Note)1,1001,100- Rental expense500500Fellow subsidiaries :- Sale of water, electricity, steam and waste materials5,3796,486- Purchase of raw materials25,13728,449- Design fee income110-Associates- Purchase of raw materials-4,824Non-controlling interest shareholders:- Sale of bulk pharmaceuticals and chemical raw materials73,79767,694- Purchase of raw materials309-Note:On 7 December 1996, the Group was granted the exclusive right to use the trademark Xinhua (Trademark) by SXPGC for its existing and future products in and outside the PRC at an initial annual fee of RMB600,000 increasing at the rate of an extra RMB100,000 per year until the annual fee reaches the cap amount of RMB1,100,000, which shall stay as such until the agreement is terminated. The terms of the agreement shall continue to have effect during the validity period of the Trademark, being 28 February 2013, subject to further renewal of the registration of the Trademark. During the six months ended 30 June 2011, the annual fee paid by the Group was RMB1,100,000 (2010 : RMB1,100,000). As at 30 June 2011, Hualu Holdings Company Limited provide guarantee to the Group amounted to RMB230,000,000 (2010: RMB230,000,000). Compensation of key management personnelSix months ended 30 June20112010RMB 000RMB 000(unaudited) (unaudited)Short-term benefits898937Post-employment benefits1201171,0181,054i!. DOCUMENTS FOR INSPECTION AND PLACE FOR INSPECTION(1) DOCUMENTS FOR INSPECTION1. The original copy of the Companys 2011 interim report signed by the Chairman of the Board.2. Financial statements for the six months ended 30 June 2011 signed by the Chairman of the Board, the financial controller and the chief of the accounting department of the Company.(2) PLACE FOR INSPECTIONOffice of the Secretary to the Board of the Company.By Order of the BoardShandong Xinhua Pharmaceutical Company LimitedZhang DaimingChairman22 July 2011, Zibo, PRCAs at the date of this announcement, the Board comprises: Executive Directors:Mr. Zhang Daiming (Chairman)Mr. Ren FulongMr. Du DepingMr. Zhao SongguoIndependent Non-executive Directors:Mr. Zhu BaoquanMr. Sun MinggaoMr. Kwong Chi Kit, VictorNon-executive Directors: Mr. Xu Lie Mr. Zhao BinPAGE PAGE 1167HJMss$d$&dIfPa$gd7v#qd$IfWD^`qgd7v]kd$$IfF#&U"    4 a8MNOPQ||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd$$IfF#&U"    4 a8QRS[css$d$&dIfPa$gd7v#qd$IfWD^`qgd7v]kd$$IfF#&U"    4 a8cdeʝ̝ghiym^^R d$Ifgd7v$d^a$gdg $d^a$ d^`$d^a$gdg d^gdg]kd$$IfF#&U"    4 a8 qx KNz|}ȝɝʝ˝̝͝ϝٝޝU^fhrĺuukY"hU4hgCJPJ\nHo(tHhU4hCJ\hU4h5CJ\o(hU4h5CJ\%hU4h5CJPJ\nHo(tH"hU4hCJPJ\nHo(tH hU4hhU4hgCJ\hU4hgh (CJ\ hU4hgCJPJaJnHtHhU4hgCJaJ#hU4hgCJPJaJnHo(tH!irwsdd$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd#$$IfFBY#T"    4 a8$d$&dIfPa$gd7vrvwǞȞϞОמ؞ٞ  >BCHIJZ[`afghiklmtu|}~Ɵǟȟƽֽ֧֧֮֮ƽ֮ hU4hghU4hgCJaJnH tH hU4hgCJhU4hgCJaJnH o(tH hU4hgCJaJ#hU4hgCJPJaJnHo(tHhU4hgCJaJo(B||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd$$IfFBY#T"    4 a8||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd)$$IfFBY#T"    4 a8ȞО؞||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd$$IfFBY#T"    4 a8؞ٞ ||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd/$$IfFBY#T"    4 a8?CI||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd$$IfFBY#T"    4 a8IJ[agss$d$&dIfPa$gd7v#qd$IfWD^`qgd7v]kd5$$IfFBY#T"    4 a8ghijk||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd$$IfFBY#T"    4 a8klmu}||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd;$$IfFBY#T"    4 a8}~ss$d$&dIfPa$gd7v#qd$IfWD^`qgd7v]kd$$IfFBY#T"    4 a8||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kdA$$IfFBY#T"    4 a8ǟss$d$&dIfPa$gd7v#qd$IfWD^`qgd7v]kd$$IfFBY#T"    4 a8ǟȟɟhijmaUF$d$Ifa$gd{/ d$Ifgd{/ d^gdH$ & FSWd1$^S`Wa$gdgd^ d^`^]kdG$$IfFBY#T"    4 a8ȟɟʟ˟͟EGghi}ݽth_Ph>h>#hU4hHCJPJaJnHo(tHhU4hHCJaJnH tH hU4hHCJhU4hHCJaJo(hU4hHCJaJhU4hHCJ\o(hU4hgCJ\"hU4hgCJPJ\nHo(tHhU4h5>*CJhU4hCJ\hU4h5CJ\o(%hU4h5CJPJ\nHo(tHhU4h5CJ\,hU4hB*CJPJaJnHo(phtH$d$&dIfPa$gd{/#qd$IfWD^`qgd{/Okd$$If440B#} 9!4 aSf4xx$d$Ifa$gd{/#qd$IfWD^`qgd{/bkd@$$If44FBY#}9!    4 aSf4ǠȠɠʠˠ!"#$&'<=?@hnʺꞌ߮v^ߌ.hU4hH5CJOJPJQJaJnHo(tH+hU4hHCJOJPJQJaJnHo(tH#hU4hHCJPJaJnHo(tHhU4hHCJaJnH o(tH hU4hHCJaJo(hU4hH5CJaJnH tH hU4hH5CJaJhU4hHCJhU4hHCJaJhU4hHCJaJnH tH hU4hH$||$d$Ifa$gd{/#qd$IfWD^`qgd{/]kd$$IfFBY#}9!    4 aS||$d$Ifa$gd{/#qd$IfWD^`qgd{/]kdO $$IfFBY#}9!    4 aSȠɠʠ||$d$Ifa$gd{/#qd$IfWD^`qgd{/]kd $$IfFBY#}9!    4 aSʠˠ||$d$Ifa$gd{/#d$IfVDg^`gd{/]kdU $$IfFBY#}9!    4 aS "||$d$Ifa$gd{/#d$IfVDg^`gd{/]kd $$IfFBY#}9!    4 aS"#$%&{{$d$Ifa$gd{/#d$IfVDG^gd{/o{L]kd[ $$IfFBY#}9!    4 aS&'=>?||$d$Ifa$gd{/#qd$IfWD^`qgd{/]kd $$IfFBY#}9!    4 aS?@x~||$d$Ifa$gd{/#d$IfVDg^`gd{/]kda $$IfFBY#}9!    4 aSnwx}~ġȡʡˡ̡Ρϡ١ڡܡݡ*+,-/0]akqĸĸָ港ĸĸhU4hH5CJaJo("hU4hH5CJaJnH o(tH hU4hH5CJaJhU4hHCJhU4hHCJaJo(#hU4hHCJPJaJnHo(tHhU4hHCJaJnH o(tH hU4hHCJaJnH tH hU4hHCJaJ,||$d$Ifa$gd{/#d$IfVDg^`gd{/]kd $$IfFBY#}9!    4 aSġȡʡ||$d$Ifa$gd{/#d$IfVDg^`gd{/]kdg$$IfFBY#}9!    4 aSʡˡ̡͡Ρ||$d$Ifa$gd{/#d$IfVDg^`gd{/]kd$$IfFBY#}9!    4 aSΡϡڡۡܡ$d$Ifa$gd{/ #d$Ifgd{/]kdm$$IfFBY#}9!    4 aSܡݡ||$d$Ifa$gd{/#d$IfVDg^`gd{/]kd$$IfFBY#}9!    4 aS||$d$Ifa$gd{/#d$IfVDg^`gd{/]kds$$IfFBY#}9!    4 aS-./$d$Ifa$gd{/#d$If`gd{/]kd$$IfFBY#}9!    4 aS/0kryzz$d$Ifa$gd{/#QWd$IfVDFWD?^Q`Wgd{/]kdy$$IfFBY#}9!    4 aSqrxyz}JN_`acȽ୛Ȉ~r~f~T~r~r~rTB"hU4hHCJPJ\nHo(tH"hU4hgCJPJ\nHo(tHhU4hCJ\aJhU4hgCJ\o(hU4hgCJ\%hU4hg5>*CJPJnHo(tH#hU4hHCJPJaJnHo(tHhU4hHCJaJnH o(tH hU4hHCJaJhU4hHCJhU4hHh3CJaJo(hU4hHCJaJo(%hU4hHh3CJaJnH o(tH yzqq$d$&dIfPa$gd{/#QWd$IfVDFWD?^Q`Wgd{/]kd$$IfFBY#}9!    4 aS`auf[C$ & Fd1$^`a$gdH $da$gdg$>d^>a$gdg$d^a$gdg$ndWD2^`na$gdgdgdg]kd$$IfFBY#}9!    4 aScdgjuĥƥѥեڥݥ(*,T`bdlnvxz˷˕~uf~T~TM hU4hg#hU4hgCJPJaJnHo(tHhU4hgCJaJnH tH hU4hgCJhU4hgCJaJo(hU4hgCJaJ*hU4hgCJOJPJQJ\nHo(tHhU4hgCJ\aJ&hU4hgCJPJ\aJnHo(tH"hU4hgCJPJ\nHo(tH"hU4hHCJPJ\nHo(tHhU4hHCJPJ\nHtH*,.`bdeO#qd$IfWD^`qgd7vOkd$$If440B#} 9!4 aSf4$d$Ifa$gd7v d$Ifgd7v~`gdg$ & FSWd1$^S`Wa$gdg$Sd^Sa$gdgdnxz|o``$d$Ifa$gd7v#qd$IfWD^`qgd7vbkd$$If44FBY#}9!    4 aSf4$d$&dIfPa$gd7vz|ҦԦ֦ڦܦ  FHNPVX\^dnpz|~ƶxxx]ShU4h5o(4hU4hB*CJOJPJQJaJnHo(phtH *hU4hgCJaJo(#hU4hgCJPJaJnHo(tH#hU4hgCJPJaJnHo(tHhU4hgCJaJo(hU4hgCJaJnH o(tH hU4hg5CJaJnH tH hU4hgCJ hU4hghU4hgCJaJhU4hgCJaJnH tH Ҧ||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd$$IfFBY#}9!    4 aSҦԦ֦ئڦ||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd$$IfFBY#}9!    4 aSڦܦ ||$d$Ifa$gd7v#qd$IfWD^`qgd7v]kd$$IfFBY#}9!    4 aSHPX}}$d$&dIfPa$gd7v #d$Ifgd7v]kd$$IfFBY#}9!    4 aSXZ\^`$d$Ifa$gd7v#d$Ifgd7voc&]kd$$IfFBY#}9!    4 aS`bdp|xx$d$&dIfPa$gd7v#d$Ifgd7voc&]kd$$IfFBY#}9!    4 aS|~tu,-FGk$7$8$H$WD^`a$gd{u $7$8$H$a$gd{u7$8$H$$da$^]kd"$$IfFBY#}9!    4 aS ԧ֧=?@AHIefsuɨʨ"#+,-EFG{|g/hU4hB*CJKHOJQJ\aJo(ph,hU4hB*CJKHOJQJ\aJphhU4h{uCJ\o("hU4h{uCJPJ\nHo(tHhU4h{uCJ\"hU4hCJPJ\nHo(tH9hU4h5CJKHOJPJQJ\^JaJnHo(tHhU4h5o(hU4h5"G|}~éѩک۩/0Ebqƪ $$G$Ifa$$G$a$$^a$"$0TPL HD@< ^ a$$ ^ a$ ^ ^|~©éЩѩ٩ک۩ܩݩީڮmT9&T&%hU4hB*CJOJQJaJph4hU4hGB*CJOJPJQJaJnHo(phtH1hU4hB*CJOJPJQJaJnHphtH)hU4h56B*CJ\]aJph#hU4h6B*CJ]aJph2hU4h5B*CJPJ\aJnHo(phtH2hU4hG5B*CJPJ\aJnHo(phtH#hU4h5B*CJ\aJphhU4hB*CJaJph,hU4hB*CJPJaJnHo(phtHEFGIVpq%()*,-ͺ棖{{m{mm{meSKGKh+zjh+zU#hU4hCJPJaJnHo(tHhU4ho(hU4hPJnHo(tHhU4hGPJnHo(tHhU4hGPJnHtHhU4hPJnHtH,hU4hB*CJPJaJnHo(phtH%hU4hB*CJOJQJaJph1hU4hGB*CJOJPJQJaJnHphtH1hU4hB*CJOJPJQJaJnHphtHƪ֪ %&'()fdGkd$$If0!64 aGkd$$If0!64 a $$G$Ifa$ )+,./1245>?@LMNOP#$a$##&`#$-/02356<=>@AGHJKLMNOP#hU4hCJPJaJnHo(tH hQrCJ h=20J$mHnHuhQr hQr0J$jhQr0J$Ujh+zUh+z/0P/ =!"H#$n% nu*l?xK-PNG  IHDRryJzgAMA pHYsLLXtcPLTE#$ 84*&'"51;7.*?;2-2./+40)%(#,(=9950,+'=83.627383B>B?A=C?@=QNUQNJFBJFXU\Y^[DAZWIF]ZOKHDWSQMMJKHSOD@YUVSLISPFCYV[W^ZROLHOLWTb_`\a^b^`]iftrfc}pn|ymjxupmvtywc`li~{}{wt}{rogdvsda~{xuebnkkgkholtqheqnpnspzw{x~}ƵG'IDATx}|yNg˲$Dz6d[r^ 8&!iP*`Ԙ˒lbh^ZQ@!M#'MI4mt/kvӦMO$nwvgyfgwgt7<3(Z8˱!}t%O_dKU}*meDW܇lL7{]+>IcMC|l4IzO̚*Irìi.! gKz8T*%,佫X ˏ<&K$]vUtɑ,VEzIyH.#Ϛ!tifPIѳf$]Nfx$]F䜳fX$]>.fpHl]Κatg&o#K>k.8ietgƾUFI9|֌4&(D2I$ʴ[K\Co~$]YgȎ*FC$A#eY/c#"OFj+ <#۠1kZǮWM?f5$=Y!R+K.>k*qبPެM`$oY _&I1k̊/ 6/~"G̚J]Y͠E-%B$cJME.s`SϒrĬ9ö"^}2JOfdGʶ*Fwt%YSYw-V21 1y oU2l"lJK=G5ڠ}>i&{1kF%03%)Iy?|Tjzώ|vK{Áw돳L&)sI:i<";ZKܔ{< 5$1FT=twLW|^2? 6{) _%R;I1fI~3Dv F)+I3kFf4b[jNv)I3k* 5lc557{"bcfMsWz_&[lJ@E"̚ K,iM%]r̬IUlr̙p +颐cfM ߽٨Ɇ7t1QQai˿.9fdUll)] @5mB*ëN* tQ~͗26w_pS Iw5km{ޕCL3u B]!G͚,6gt9fִ: qsѪ”%(Y(iD TW#fMA$)/pY AA8z=CfMQ`J/{]MYS:Naq&(D08J;0tCfMQ@ "4\ҝfȶsidz?t;"G͚DtGaJJrܬs"paL IE5yBRlLB ͚.BSl鱊1;K;O9kz~"bsz s[QG#gMe~6iDjcLI!GΚ~ؤS\m%]Κ~$N#)}BܬQ`]j]|sa\Q#y0Y >/ <ʔ>&FzQœt/8EXlFt<ʔ_k=+= 071ox ɕpAqQj] *>~.6Q,tzM (Q_6\#frRLQB]uIRvpzM eۣ|mwJ63;VVX RԣLQ']iѧ3O޵ˍznq(ybE>)ΉFIX88S:U ,U3sdθT`"NBBonaEBORVV+x2j ' s%NR08E=ƓGVhbf#i+zbiӪ8SR"DKnb5rSWMu;6rH[!V#3S0Ow.Bd.A#[̕`XPg #ȂE#/93fZeɌ\S{<03Ol#4 2)J{d<=`[Sԗ ˀ\S%-x,-|@u=݅}55FJ77(\dcs'`}IIFKgnFmNڳw8B?Hz,s-ډ-}ֽ-V,a \954O|\*Kѹ\nW"ZO_^6MSa&y <07t|-s<7{<2*C6m,^YZ=@9Q(iE0b+ANlzQ~O9Q_\jVv^X !*y{F0DiR#ϲӓO5||@c|ȋA^Ɍ=t*"GIgPݙ-M> 9RP86uimڰJsp>/;|(|=i :\2noi@ Wߍ}kj qg@>a19i?K]~되>>7xlgߗ@g sh.~K|~ xs>"¹7U­Ůһ4vvg^i4so8xgkSdpG+'rmS}̈́ð)wh39jkku?ʒa@VfN6:%BwSTjc9u h5#p%k _=ANWvm)eͯlW+RuKw)]zYv})K-_%)kxb[nZ TVdxN~Uwjb;? bPVWȵ!|,<}qP ~9kZgL/g}lIV6z tNyPw\ܵ!1[gtwA[h%#N0y@d z|+C ŕ5G.Yn1<'`MMM7}dy(B#,yKg\7S;w²n r<0w :ҹ0)oux9֖~e⯖gs4[_Sۿ[ rf;G^8}EO{뢂G\Y/XId(Wp=Lh+ve7(so+}Gi'Mp_kk'KD74mфG-1 >cUƱe9 +5?r/:i@~D Gu݅fIZ`UEN 'D%=u\ 3A~ YoaEٷs7Dޠ_E8@-J1|s )rOAO.мE%!185<Ӧi_r`/qc/*!wR?̱+[=aǎ0{̱~}ee];Mf-nz1_W<o5O_cc>YF3>xפ@r.GΏcM]G}EuT)My+78ϻﵱ7Wa=U=_sYjr uK7xCuQ_?Yf n% ؜G-Y`n9 R9؆۳˔F„܀?mG^ {:Fߘ2C7CTk=\@pFk}j&'jv r5qC[:+@ުv߈MarCij BNԓ~P-w9j| 4E"G9 eljUc9!~sS̊PSFF:"YeSC\yHf GL2;6h3c&TiWyf|;tk$o59Yh{w{QȉJN,tΐH#\2*ّ$ʥ ~G0M}"'߇ǽ#FCx#;]vkr"']yVjMN\wn^ZǡWZ#Oo3w,J1G%EBOM_!X#ׯͦۡ"'rLQ5r})mx }M(%r3>QH}/yfN^܌ur"ȹOf5Z.\F|ߩch !~ kn*e#7vReUS8%!G~e`[pCheeAUsn+dz.~#GF3ܟ 9fu<' tW:H<:Kg I;N]:֜op?vԼ,Bkm܍VE8'w c$a_SPTVn58pi.7Ȋ|֜N)meX>wK*)07f^xz)G4w0oVjtP\RQ^so= PկMAwoIң_:û]ul#t0tHq}g:v.;'ѻ\^Vz9WʽRm5ݪ~yv N}Y!Pr&lj&(9f4@k|9!KE\oEqo*<#Z8kcu#QMe"w,:p/ė%"'W+S3'rN"Cr{\]^-P:~pOqL /r[+:@0#ֳ!9bb0,~[;|oB-l$rS't| !G4>ޱ ANg\RSVtDåZ-rTuif=˿1ȭ$K!O8f;`ŽsݦFvzozpWލ+++^=aG>@W2۱ή^=":۷{Eeu}sǂX>h#'Jg 3'U y>K ;rMyUQ v77- ?r*3arCޛ}u7^=n^n7]Vjz~T,PT|' %zo^ IL]" *^e6rg2OCy|l oPVmR rK?1f>B7pvk^77eT$r*gFE/AFj69iF= )N75u cy~iFƧ s|n14#kꑎ,EwA"^(m<x$|Drn=2P Wʻ Sp J<񉲋Jܔ3U=F/5>JtM"@4j|:@ !,rE/*քU5lώU}Mmy=wMu%{nA܇+ߒnzkݼhMBt#`+iyWw T?%EeM}'jӖb76f5`D<$Z $}7uQdk"%Z CrŃ⏤79#㦪5ǥDxOQEWaTnePu}?L(*hc^*R^QbEP/{ |%.#;f?d ?iKz $"l+is=x(J|kc.85`(hJ(l_sY^c%NQHiЕĶXĻCY#+=raDF+CBb~X?ĉx >< ptAwEԜӇjZRI7f. qmZ8CbeA!x%%p/ =K5Q$ݴkG\#^UC6I7rfU;o6n^6 _)ꊝeml 1vi,w.x4̉J.8IoIýlw'kmb JSQ>c釐<7 HһGGZSKG{WD{s{i\^6 <$=ߍq3htcS<W} 4|lMbϛvU*=8N1g,3{6]"Iqԋ[$|V'[g 4rgrH:X^6rWoqH8*n+t0E}hW f%&PQ U籤CE<L%.Iq`JmDCBO> NotesdB*CJaJphHOH Subhead 1Td^T ;CJaJ~O~ Subhead 2B$'PL HD@<Q^`a$5B*\phO Body textc$>TPL HD@<Td1$7$8$H$^Ta$-B*CJOJQJ_HaJmH nHphsH tHDZ@D ~e,g$a$CJOJPJQJaJnHtH<O< write $a$CJPJnHtHpOpChar Char Char Char!d1$CJKHPJaJmHnHtHu.@". yblFhe,g"CJaJ6 @26 u#9r G$CJaJ)@A uxP@RP u w%!d1$CJKHOJPJQJaJtH 0b0 le,g&G$CJaJPOrP Anrede' 1$KHOJPJQJaJtH VOV W[CQ W[CQ(d1$CJKHPJaJmHnHtHuPQ@P ckee,g 3)$a$!B*CJOJPJaJnHphtHBL@B eg*$a$CJOJPJQJaJnHtHvOv Report Text-+$d1$5$7$8$9DH$^a$KHPJaJmH sH tH VT@V e,gWW!,$:d1$]:^a$CJKHPJaJtH `O` Default-1$7$8$H$)B*CJPJ_HaJmH nHphsH tH*U@* c >*B*phXOX xl137/dd1$[$\$ CJKHOJPJQJaJnHtHpOp Body Single0$ (1$a$$B*CJPJ_HhmH phsH tH 2V@2 ]vc >*B* ph0`@"0 HTML 0W@W26]Be@2B  HTML @BP h4$<@&a$5CJ OJPJQJ\^JaJ K@ y|T5([@b( 5uP[N~{T6\J@r\ oRh7$d8<@&a$"5CJ KHOJPJQJ\^JaJ - [e,g48 ` @ 1$3$5$7$8$G$0CJKHOJPJQJ^J_HaJmH nHsH tH6%@6 [ON0W@W9G$ OJQJ^J.?@. ~_g:dVD4^d4/@4 Rh;8WD8^`8<2@< Rh 2<d8VDWD8^d`8<3@< Rh 3=d8VDWD8^d`8<4@< Rh 4>d8VDXWD8^d`8<5@< Rh 5?d8VD WD8^d`8,1@, RhS @ & F 0:@0 RhS 2 A & F 0;@"0 RhS 3 B & F 0<@20 RhS 4 C & F0=@B0 RhS 5 D & F4D@R4 Rhc~ExVD^8E@b8 Rhc~ 2FHxVD^H8F@r8 Rhc~ 3GxVDX^8G@8 Rhc~ 4HxVD ^8H@8 Rhc~ 5I4xVD^400@0 Rhyv&{S J & F46@4 Rhyv&{S 2 K & F47@4 Rhyv&{S 3 L & F48@4 Rhyv&{S 4 M & F49@4 Rhyv&{S 5 N & F$$vU_ 1O00vU_ 2PVD^00vU_ 3QHVD^H00vU_ 4RVDX^00vU_ 5SVD ^00vU_ 6T4VD^400vU_ 7U VD^ 00vU_ 8V| VDx^| 00vU_ 9W VD@^ $$ ybleW[X*j* ybl;NY5\(^@( nf(Qz)Z,@@, ~{T[dVD4^dX$@X 6eON0W@W(\d&+D/G$VDx^d OJQJ^J$ $"}_ 1]0 0"}_ 2^VD^0 0"}_ 3_VD^00"}_ 4`XVDX^X00"}_ 5a VD ^ 00"}_ 6bVD^00"}_ 7cVD^00"}_ 8dxVDx^x00"}_ 9e@VD@^@6!6 "}_hf5OJQJ\^J8"8 lgCJOJPJQJ^JaJ4#4 VhvU_h8VDWD8`8(+( >\le,giG$8Y8 ech~gVj-D M I@ Oo`hok8$d%d&d'd-DM NOPQVDWD ^8` OJQJ^J0,0 _evU_lVD^<.< _evU_hmxOJPJQJ^J(B@( ckee,gnx4M@4 ckeL)ۏoWDd`8C@8 ckee,g)ۏpxVD^8N@8 ckeL)ۏ 2qWD`0@"0 cke)ۏrWD`2P@22 ckee,g 2 sdxBR@BB ckee,g)ۏ 2tdxVD^DS@RD ckee,g)ۏ 3uxVD^CJaJ*O@* lʑhv$a$TOrT 7h_1wdd1$XDdCJKHPJaJhmH sH tH 6O6 short_text1CJaJZOZ Table Texty$a$$B*CJPJ_HhmH phsH tH ZOZ Table Text Char$B*CJPJ_HhmH phsH tH JOJ body text{xx1$CJKHaJtH VOV RQk=|d1$WD`CJKHOJPJQJaJtH <O< tw4winMark<B* H*phVOV gnUk=~d1$WD`CJKHOJPJQJaJtH 8O8 c!apple-style-spanO c!hpsBOB c!apple-converted-space& 78#$89CDhist  efyzĨŨ1$%noK00)0 K00@)@0K00PX=@0 K00X=@ OJQJo(K00X=@&K00X=@0K00 0Y=B20?0@0K0@0Ah@0|lK0B0Cq<'` K0D0E@0K0F0G@0Pah K0H0I}@0K0J0K~@0f2 qrsuv"DE*:;cdLMghK   ) * 3 4 i j   J T     / > @ A 78O`qwx(6;<.38MN16;CDEKhmzVc"#$*789:cd1:CDZahi  .EOP]hst%8MNdr  1<GVef  Vcp}FGbcdp{|)/5<BCWY[]_`}$078\ho{    I!J!!!!!"%"B"m"""""# # ###(#8#D#J#L#N#O###############$$$#$%$'$($4$D$L$Q$S$U$V$c$s${$$$$$$$$$$$$$$$$$$$$$%% % % %%%%%%%%%%%%&&$&%&[&f&o&p&}&&&&&&&&&&&&&&&&&' ' '' ')'*'2':'C'D'E'K'L'H)I)**'+(+++....H/I/N/W///////////////////00 0 00-0105090:0H0]0m0q0u0y0z0000000000011 1 11014181<1=1M1p1t1x1|1}11111111112222 2 2 2 2222222202R2V2Z2^2_2m2x2~2222222222222222222222 3 3 333335393=3A3B3P3h3l3p3t3u333333333333333444 44444 4!4"4448888A9B9Z9[9n9o999';(;K<L<<<<<>>>>RBSBBBDDFFFFHH_J`JJJM MNNNNPPfQgQQQ[R\RSSeUfUjXkX[[7]8]v^w^^^~____\a]aaaLcMcCdDdddfegeffffggggGhHhkkUkVk{o|osstt?tRtetftgtvt|tttttttttttttttttu uuuu"u)u0u7u>u?uEuOuYucumunuouuuuuuuvv v!v.v6v>vPvQvnvvv~vvvvvvvvvvvwww>w?wEwVwhwiwjwyw~wwwwwwwwww xxx x'x(x?xNx]xnxyxzx{xxxyyyyyyyyzz#z$zLzSzWz^zezgzhzzzzzzzzzzzzzzz{ { {{{#{${;{B{D{K{S{]{^{d{l{p{x{z{|{}{~{{{||||n}o}}}}}{~|~ĀŀFGׄ؄ͅ΅GH_`,-hitɇNanov̈ ,.9]fgm{}}~klˍ̍ۍMNZx*+fg}~/0#$12 8{|ǘԘ.=>[l{řԙ!0APQlyȚ֚ "0>LMhvɛ˛͛ϛЛ%2?LYZÜМݜޜ%3AOPlwŝҝߝ&1<GRSm{žОݞ .<JKϟП  !"#$BGLQVWw|Ǡנ"0>?ɡסء+-:<=>?FG !)*+,8DEFGHIJRT^hiwxǤȤΤԤդ ;<ENOghqz{ĥʥ˥٥ڥ ')2;<=>?@AZ[bijklmno¦æݦަ.09BCDE~ɧէ֧קا٧ڧۧ 01234`mqyzĨŨ RS[defghijة٩ک۩ܩ#)*+,-./018?@ABCDEG~ƪЪѪҪӪԪժ֪$%-78QRZbcīūޫ߫34:@Arsz¬ʬҬӬ,-39:WX\^_ṷ̆ͭ56=CDEFGHIJKU_`abcdeyz{|}̮ͮӮٮڮ !)123456789AIJůƯί֯ׯدٯگۯܯ23456DEMUV_`jtuʰ˰հ߰ '1234567OPQRSlmsyzƱαϱбѱұӱԱձֱ;<UVLMkmѵҵ̶ͶyzcdvŸƸ&bcd[\qȺ >?H`asۻܻ-.=klm6{|VW*+Z[*+01BCYUVWXYv de "*2:;<=>?@ABCKLMNOPQRcks{(/6<BCJKLMNOPQRSpqrstu|} $%&'()012cdef{|} 08@HOQ[\pv~  <=>?@AHI`abcdekl{|}~PQlmn &.89:;<=>?@]^_`aijklmnopq #+3;<=>?@ABCR\dlt~678=BCDLTUVbnopqrs 8?FGntz{%(./0FG)078LQWXYZ[\ov}~67]^vwQR_`XYZstuzqrst{|}~$%^fnopqrst|!"#$%&HPXYZ !"#+345ALMNOPQaiqr rt123;CDEQ[\]^_`px %&IQYZ[\]^_gopq+,-2789AIJKXdefghipqrs &,-IPWXlprstuvw!"?CEFGMN *.23LPTUVWXYZ`fgh$%&<ky '89^n~000000000000000000000000000000000000000000000000000000000000000000 00 00 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0 0 0 0 0 0 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0--- - - 0 w 0 w 0 w 0 w 0 w 0 w 0 w 0 0 0 w 0 0 0 w 0 0 0 0 0 0 0 000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0000 0000 0  0 0 0 0000 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000000000000 0 0 0 0 00 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 v0 0 0 0 0 0 000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 "0 0 0 0 0 0 0 "0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 "0 0 0 0 "0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000 00 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 y0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000000000 0 0 0 0 0 0 0 0 0 0 0 000000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0000000000000 %0 %0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 '0 '0 0 00000 %0 %0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0     0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 0 %0 % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0 0 0 % % 0 0 0 % % 0  0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 %% %% 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 %0 0 0 0 0 %0 0 0 0 0 0 0 0 0 0 0000000 000000000  0 0  0 0  0   0   0 0  0 0000  0 0 0 0   0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000 00,,0 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 ,0 00 00 000 00 0 000 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 000 00 0 000 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 #0 0 0 0 0000 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 000000000000 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0000 0000 0 0000 00 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 0 #0 #0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 0000 00 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 00000000 00 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 000 000 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 #0 0 0 0 # 0 0 0 # 0 0 0 #0 0 0 0 # 0 0 0 # 0 0 0 0000 00 0~0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 0000000000000000000000000000 00000 0 0000 0 0 0@0I00@0I00@0I00@0I00@#0@#0@0@#0@#0@0I00(qrsuv"DE*:;cdLMghK   ) * 3 4 i j   J T     / > @ A 78O`qwx(6;<.38MN16;CDEKhmzVc"#$*789:cd1:CDZahi  .EOP]hst%8MNdr  1<GVef  Vcp}FGbcdp{|)/5<BCWY[]_`}$078\ho{    I!J!!!!!"%"B"m"""""# # ###(#8#D#J#L#N#O###############$$$#$%$'$($4$D$L$Q$S$U$V$c$s${$$$$$$$$$$$$$$$$$$$$$%% % % %%%%%%%%%%%%&&$&%&[&f&o&p&}&&&&&&&&&&&&&&&&&' ' '' ')'*'2':'C'D'E'K'L'H)I)**'+(+++....H/I/N/W/////////////////00 0 00-0105090:0H0]0m0q0u0y0z0000000000011 1 11014181<1=1M1p1t1x1|1}11111111112222 2 2 2 2222222202R2V2Z2^2_2m2x2~2222222222222222222222 3 3 333335393=3A3B3P3h3l3p3t3u333333333333333444 44444 4!4"4448888A9B9Z9[9n9o999';(;K<L<<<<<w^^^~____\a]aaaLcMcDdddfegeffffgggGhHhkkUkVkstt?tRtetftgtvt|tttttttttttttttttu uuuu"u)u0u7u>u?uEuOuYucumunuouuuuuuuvv v!v.v6v>vPvQvnvvv~vvvvvvvvvvvwww>w?wEwVwhwiwjwyw~wwwwwwwwww xxx x'x(x?xNx]xnxyxzx{xxxyyyyyyyyzz#z$zLzSzWz^zezgzhzzzzzzzzzzzzzzz{ { {{{#{${;{B{D{K{S{]{^{d{l{p{x{z{|{}{~{{{|||n}o}}}}}{~|~ĀŀFGׄ؄ͅ΅GH_`,-hitɇNanov̈ ,.9]fgm{}}~klˍ̍ۍMNZx*+fg}~/0#$12 8{|ǘԘ.=>[l{řԙ!0APQlyȚ֚ "0>LMhvɛ˛͛ϛЛ%2?LYZÜМݜޜ%3AOPlwŝҝߝ&1<GRSm{žОݞ .<JKϟП  !"#$BGLQVWw|Ǡנ"0>?ɡסء+-:<=>?FG !)*+,8DEFGHIJRT^hiwxǤȤΤԤդ ;<ENOghqz{ĥʥ˥٥ڥ ')2;<=>?@AZ[bijklmno¦æݦަ.09BCDE~ɧէ֧קا٧ڧۧ 01234`mqyzĨŨ RS[defghijة٩ک۩ܩ#)*+,-./018?@ABCDEG~ƪЪѪҪӪԪժ֪$%-78QRZbcīūޫ߫34:@Arsz¬ʬҬӬ,-39:WX\^_ṷ̆ͭ56=CDEFGHIJKU_`abcdeyz{|}̮ͮӮٮڮ !)123456789AIJůƯί֯ׯدٯگۯܯ23456DEMUV_`jtuʰ˰հ߰ '1234567OPQRSlmsyzƱαϱбѱұӱԱձֱ<UVMkmѵҵ̶ͶyzcdvŸƸ&bcd[\qȺ >?H`asۻܻ-.=klm6{|VW*+Z[*+01BCYUVWXYv de "*2:;<=>?@ABCKLMNOPQRcks{(/6<BCJKLMNOPQRSpqrstu|} $%&'()012cdef{|} 08@HOQ[\pv~  <=>?@AHI`abcdekl{|}~PQlmn &.89:;<=>?@]^_`aijklmnopq #+3;<=>?@ABCR\dlt~678=BCDLTUVbnopqrs 8?FGntz{%(./0FG)078LQWXYZ[\ov}~67]^vwQR_`XYZstuzqrst{|}~$%^fnopqrst|!"#$%&HPXYZ !"#+345ALMNOPQaiqr rt123;CDEQ[\]^_`px %&IQYZ[\]^_gopq+,-2789AIJKXdefghipqrs &,-IPWXlprstuvw!"?CEFGMN 23TUXYZ`fg000000000000000000000000000000000000000000000000000000000000000000000000000 0 0 0 00 0 0 0 0 -0 0 0 0 00 0 0 0 00 00 00 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00-0-0-0 -0 -0 0 w0 0 w0 0 w0 0 w0 0 w0 0 w0 0 w0 0 0 0 w0000 w0000 0000 000000000 0000 0000 0000 0000 @0K00@0 0000 00000000 0000 0000 0000 0000 000000000  000000 000000 000000 00 000000 000000 000000 000000 00000000000000000 0 0 00 00 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v0 0 0 0 0 0v000000000000000 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0"0 0 0 0 0 0 0"0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 000000000 0 0 0 0 0 00000 0 0 00 0 0 00 0 0 00 0 0 0"0 0 0 0"0 0 0 00 0 0 00 0 000 0 0 0000 00 0 0 000000000000000000@0 @0 K00k@00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 00 0 0 0 0 0 000 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00000000000000000000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 000 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00 0 0 0 00000 0 0 0 0 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 0000000 00 00 00 0 0 00 0 0 0 0 0 00 0 0 0 0 y0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 00 00 0 0 0 0 0 0 0 000000000000000 0 0 0 0 00 0 0 0 0 0000000000000000000000000000000 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 000 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00000 0 00000 0 00000 0 00000 0 00000 0 00000 0 00000 0 00000 0 00000 0 00000 0 0 0000 0 0 0000 0 0 0000 0 0 0000 0 0 0000 0 0 0000 0 00000 0 0 0000000000000 %0 %0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 '0 '0 0 00000%0%00 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 0000 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0%0 %0%0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 00%0%00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 %0 0 0 0 0 %0 0 0 0 0 0 0 0 0 0 00000 000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000000000000 0000000000000000000000000000000000 00,0,00 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 ,00 0000000000000000000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 0000000000000000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000000 00000 0000000 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 000000 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 00000000000000000000 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0000 0000 0 00000000 0000 0#0#00 0#0#00 0#0#00 0#0#00 0#0#00 %0000 %0000 %0000 0#0#00 %0000 %0000 %0000 %0000 0000 00 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 00000000 00 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 000 00000 #0000 #0000 #0000 #0000 #0000 #0000 #0000 #0000 #0000 #0000 #0000 #0000 #0000 #0000 #0000 #0000 #0000 #0000 #0000 00000 0K04H.0 K04.0 K04.0 K04.0 K04(.0 K04`.0 K04.0 K04Л.0 K04  K04 K04 0 K03(w}0 K03`w}0  %%%( P moHTF"e ",$$-&&'),,/0146;>V??oAkBCDHMOPRY\_`bcdfjw!$&(-6GQV_jpwx  yF=f_CzC f x"""J##,$z$ %%&-&q&Z''(k(()o))K,,[----1.A...3/t/E182222)3*3Z3[333333344C4D4m4o4W55556/6N6l666>>/?D?l???<@l@@@AhAnAAAA BTBZBpBBB C?CjCCH+Vgtǃ*R|τK8eʆ@ۇ6ފW/З[lȘϘ"o[ t(KI&^4YCO&_z>.ap +Hoѷ!BGjŸAFW\׹,1Z_кhm2Xݼ',C\Du׾ܾ )X#LQh0Qk-2ns6`e%*AUijB?L+_a#%+3gio,Jf,F_frv4;Snsw',0OTXD,p$2 "3/5_B )DH 1JN{dhx|x6MQci؞Igk}ǟʠ"&?ʡΡܡ/ydҦڦX`|Gƪ)P    "&-/012345789:;=?@ABEFGIJKLNQSTUVWXZ[]^aeghiklmnopqrstuvxyz{|}~     "#%')*+,./012345789:;<=>?@ABCDEFHIJKLMNOPRSTUWXYZ[\]^`abcdefghiklmnoqrstuvyz{|}~   O:J.QeL t XXXX !(!!l,b$l?xK-}*1&@(  f  c 6A!SHANDONB S  ?s`8t _Hlt267921118_Hlt267921119 OLE_LINK10 OLE_LINK11 OLE_LINK2 OLE_LINK3_Hlk267059321 OLE_LINK8 OLE_LINK9 OLE_LINK33 OLE_LINK6 OLE_LINK7bbJJJ++@@ ccCCC44+p`plVPp_pVPp^p,jp^pljpVPp,WPpjpįTp,kplkpkpkpTpTp$TpdTpTpTpdTp$Tp$TpTpdTpTpapap$apdapapap$apdapapap$apdapap\p\  }   BBBBLB6G6G=G+J+J5JKKffffgh-mttttxvvދ     !"#$%&'()*   KBPBPB0@0A0G00000E1L11111&2/2g2l2222233F3H3I3O3|33333333]>e>BBKBEEEEEEEE6GevV %V[S& q-4#f\e;7v`R70^uEY`Q\F`9iUԽ^ c"V$FB`[z.1nrvr VD WD8^`. TTVDXWD8^T`. VDWD8^`.   VDWD8^ `. VD WD8^`OJQJo(l TTVDXWD8^T`OJQJo(l VDWD8^`OJQJo(l   VDWD8^ `OJQJo(lhhWD8^h`. hhWD8^h`OJQJo(l--^-`o(()  ^` hH0 e e^e` hH. E  E ^E ` hH. %  % ^% ` hH0  ^` hH.  ^` hH.  ^` hH0  ^` hH.8^8`o(. \^`\hH) \^`\hH. ` \^` `\hH.  \^ `\hH)  \^ `\hH. L\^L`\hH. \^`\hH) \^`\hH.8^8`PJo(.  ^` hH0 p ^p` hH. P  ^P ` hH. 0  ^0 ` hH0  ^` hH.  ^` hH.  ^` hH0  ^` hH.9^9`o(() \^`\hH) \^`\hH. a\^a`\hH.  \^ `\hH)  \^ `\hH. M\^M`\hH. \^`\hH) \^`\hH.0^`0o(. H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.hh^h`PJo(0 H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.hh^h`o(.  ^` hH0  ^` hH.  ^` hH. `  ` ^` ` hH0 @  @ ^@ ` hH.    ^ ` hH.  ^` hH0  ^` hH. ^` o(hH.  ^` hH0  ^` hH.  ^` hH. `  ` ^` ` hH0 @  @ ^@ ` hH.    ^ ` hH.  ^` hH0  ^` hH.hh^h`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .p^p`PJo(() P\^P`\hH) \^`\hH.  \^ `\hH. < \^< `\hH)  \^ `\hH. \^`\hH. (\^(`\hH) \^`\hH.0^`0PJo(. H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.hh^h`PJo(. H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.--^-`o(() ^` 0e e^e` .E  E ^E ` .%  % ^% ` 0 ^` . ^` . ^` 0 ^` .^`PJo(() \^`\hH) @\@^@`\hH. \^`\hH.  \ ^ `\hH) , \, ^, `\hH.  \ ^ `\hH. t\t^t`\hH) \^`\hH. ^` PJo(.  ^` hH0  ^` hH.  ^` hH. `  ` ^` ` hH0 @  @ ^@ ` hH.    ^ ` hH.  ^` hH0  ^` hH.e;7S&iU`[c"V A5vV %\FR7~}|1nrcr uEq-E;(N        U        |:        TL        ^n                m2o                 4S        |d0]        kP                                ހ        e X- ! 5 #: %/ Pq9^} e}T,% | p"#A$u|$@C%!S%t%l&%*-9.9`/{/X2)5ua5B5&6;=;X>?@BAB 5JMJMdOP%Q6RHpSCcTpV&WR[bc]o}_ k`Cicvholm`n.oAo/pxpIrQr t[t{uYuCvPw'xnze{| _|S~-8_[= %OHc! 2lI6Tl'gqu9[[_ez'Z2i7vU4Sd7y&r]xAenjVO"x n'@ux#+z ,Tcx%?WXL_+?G}~^c`(t X^=22;<EFZ6}5O:wm;MNYf*  T     / > @ A 78O`qwx(6;<.38MN16;CDhmzVc"#$*789d1:CDZahi  .OP]hst%8MNdr  1<GVef  Vcp}FGcdp{|)/5<BCWY[]_`}$078\ho{   !!!"%"B"m"""""# # ###(#8#D#J#L#N#O###############$$$#$%$'$($4$D$L$Q$S$U$V$c$s${$$$$$$$$$$$$$$$$$$$$$%% % % %%%%%%%%%%&&$&%&[&f&o&p&}&&&&&&&&&&&&&&&&&' ' '' ')'*'2':'C'D'I/N/W///////////////////00 0 00-0105090:0H0m0q0u0y0z00000000011 1 11014181<1=1M1p1t1x1|1}11111111112222 2 2 2 2222222202R2V2Z2^2_2m2x2~2222222222222222222222 3 3 333335393=3A3B3P3h3l3p3t3u333333333333333444 44444 4!448<g>Cdst?tRtetftgtvt|tttttttttttttttttu uuuu"u)u0u7u>u?uEuOuYucumunuouuuuuuuvv v!v.v6v>vPvQvnvvv~vvvvvvvvvvvww?wEwVwhwiwjwyw~wwwwwwwwww xxx x'x(x?xNx]xnxyxzxyyyyyzz#z$zLzSzWz^zezgzhzzzzzzzzzzzzzzz{ { {{{#{${;{B{D{K{S{]{^{d{l{p{x{z{|{}{itɇNanov̈ ,.9]fgm{}̍ۍMNZx|ǘԘ.=>[l{řԙ!0APQlyȚ֚"0>LMhvɛ˛͛ϛЛ%2?LYZÜМݜޜ%3AOPlwŝҝߝ&1<GRSm{žОݞ .<JKϟП  !"#$BGLQVWw|Ǡנ"0>?ɡסء+-:<= !)*+,8DEFGHIJRT^hiwxǤȤΤԤդ ;<ENOghqz{ĥʥ˥٥ڥ ')2;<=>?@AZ[bijklmno¦æݦަ.09BC}~ɧէ֧קا٧ڧۧ 01234`mqyzĨŨ RS[defghijة٩ک۩ܩ#)*+,-./018?@ABCDE}ƪЪѪҪӪԪժ֪$%-78QRZbcīūޫ߫34:@Arsz¬ʬҬӬ,-39:WX\^_ṷ̆ͭ56=CDEFGHIJKU_`abcdeyz{|}̮ͮӮٮڮ !)123456789AIJůƯί֯ׯدٯگۯܯ23456DEMUV_`jtuʰ˰հ߰ '1234567OPQRSlmsyzƱαϱбѱұӱԱձֱ;VLyzcdvŸƸ&bc[\qȺ >?H`asۻܻ-.=klBCYUVWXYv "*2:;<=>?@ABCKLMNOPQRcks{(/6<BCJKLMNOPQRSpqrstu|} $%&'()01cde{ 08@HOQ[\pv~  <=>?@AHI`abcdekl{|}~PQlmn &.89:;<=>?@]^_`aijklmnopq #+3;<=>?@ABCR\dlt~678=BCDLTUVbnopqrs 8?FGntz{%(./)078LQWXYZ[\ov}~XYZstuzq{$%^fnopqrst|!"#$%&HPXY!"#+345ALMNOPQaiqr t123;CDEQ[\]^_`px %&IQYZ[\]^_gop+,-2789AIJKXdefghipqrs &,-IPWXlprstuvw!"?CEF *.23LPTUVWXYZ`fg9y0}wUNaja2a2a2a2a2C[&[&a2a2a2a2a2 0{Oa2a2a2)roxUco@DjDj0DjDj!0vv `@` `@``$@``0@`"`$`L@``P@``X@``@``@````@`8 @``P @Unknown Lenovo UserStephen TsangUserGz Times New Roman5Symbol3& z ArialKE  .DFKai-SBPMingLiU;[SOSimSunC .PMingLiUe0}fԚ9: ZWAdobeF3Times] Times-BoldTimes New Roman_ Times-RomanTimes New Romanc HelveticaNeueLTStd-LtMingLiUU Arial Unicode MSArialSMHeiHK-LightPMingLiU;ўSOSimHei?5 z Courier New[ (DFPFangSongW4-B5PMingLiU?E  eckwiSO_GBKўSO;Wingdings F0fifhlifhl!xxdee**2qHP?O2 2006 ANNUAL RESULTS ANNOUNCEMENTWonderful Sky_o(u7bp                    Oh+'0(8 LX x  $2006 ANNUAL RESULTS ANNOUNCEMENTWonderful Sky$generated by an Adobe applicationNormal ΢û143Microsoft Office Word@B@ovF@D[3-@+GHifh՜.+,D՜.+,  `h Wonderful Skyle  8@ _PID_HLINKSARF http://www.cninfo.com.cn/??mailto:xhzy@xhzy.com?OGhttp://www.xhzy.com/?yPmailto:guolei@xhzy.com?  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'(*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry FBGHData )_1TableWordDocumentPSummaryInformation(DocumentSummaryInformation8CompObjm  FMicrosoft Office Word ĵ MSWordDocWord.Document.89q